Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Vibrio fischeri ES114, ES114

>VFA0800 maltose/maltodextrin transport ATP-binding protein MalK
MTSVTLRNVCKSYGDVKISKNVDLDINSGEFVVFVGPSGCGKSTLLRCIA
GLEDITSGDLYMGDKRMNDVEPSKRGVGMVFQSYALYPHLNLFDNMSFGL
KLAKADKNEIKKRVDHAADILQLGHLLERQPKALSGGQRQRVAIGRTLVS
QPDVFLLDEPLSNLDAALRVQMRIEIAKLHKKLGCTMIYVTHDQVEAMTM
AEKIVVLDGGYVSQVGAPLELYHYPKNRFVAGFIGSPKMNFVSVFIEEVE
KSQVKVQFKNGASFWIPVDGSNVKRGERMSLGIRPEHLVPAENGDAVIDG
DILVVEKLGYETQIYLTIEDGDADMIYRVPDTALVKAGERFSVGIPAHRC
HLFHNDGKACQRLYKEAGV
>VF0441 D-erythrose 4-phosphate dehydrogenase
MLRVAINGFGRIGRSVLRALYESDKRDKIEVVAVNELSQPEAMAHLFQYD
STHGRFQHKVTHDQEYPYSDVPDSSQDKVRILHQADLSLLPWQSLEVDLV
LDCTGVYGSKSDGEKHITAGAKKVLFSHPGGSDLDNTIIYGVNHDTLLPE
HRIVSNGSCTTNCIIPVIKAIDDAFGIDSGTITTIHSSMNDQQVIDAYHS
DLRRTRAASQSIIPVDTKLHKGIERIFPKFSNKFEAISVRVPTVNVTAMD
LSVTINTNVKVNDINQTIVNASRCTLHNIVDYTEAPLVSIDFNHDPHSAI
VDGSQTRVSNGHLVKMLVWCDNEWGFANRMLDTALAMSK
>VF1330 hypothetical protein
MYKPRGSLVTAYLTLLISTSVVASNTPLKKDNVPPSELPPIQIKHTPMFI
SLGFDDNVEKDGLEWVIKELKKNKNPDGNDRFANLPLSASFFMHCAPARE
NTEIKKLWRQLVTDNHDIGNHTETHPDDKVNYNPLTSWMTPEQWHTEVAD
CNKLLMAASDNGGLGIEHVSGFRAPYMTYNDNTLNALIENNIVYDVSFPA
GITPEQNGQNNYWPYTLDNGSPSHNAAVSGWWKPVINNYPGLWEIPLHTL
IVPPDELLEQYELNYSLRDKIASRISYFDPISGKGDNFDWNLYSTPNWGA
AGLNENDVVAIYKYNLDLRIQGNRAPLVLGLHSAFYGYIGGEEHIGMPES
NVDTRRNVLKRFIKYALSKPEVRFVNHKQIIDWMRTPEPLTLCPQEEWKP
HQVYIKGETVNFQGKMWQAQWWTQLQQPGLTESSPWKKVTSCT
>VF0090 4-hydroxy-2-oxoglutarate aldolase
MSWNLSPSDVFSASPVVPVMVIEQLEDAVPMAQALAAGGINVFEITLRTA
VALEAITAIRKAMPKALVGAGTVISTHQYDQAVEAGAQFIISPGFTPSLL
AHAKTADVPLIPGVATPSEVIRAIELGYSHLKFFPASAFGGPSVLKAMAA
PLPQVQFCPTGGINPQNVNDYTALDCVATVGGSWMLPKDAVAAKDWNKVT
LLAKEAVELIK
>VFA0494 pyruvate kinase
MSNRLRRTKIVTTLGPATDRDNNLEKIIAAGANVVRMNFSHGSPEDHIER
TRKVREIAAKLGTHVAILGDLQGPKIRVSTFKEGKIQLAIGDKFTLDSDL
PKGEGNQDSVGLDYKELPQDVTTGDVLLLDDGRVQLRVTAVEGNKVHTEV
TVAGPLSNNKGINKQGGGLSADALTEKDKADIITAAAMKVDYLAVSFPRN
GEDMNYARRLARDAGLEAQLVAKVERAETVASEEALDDIILASDVVMVAR
GDLGVEIGDPELVGVQKQLIRRARSLNRTVITATQMMESMISSPMPTRAE
VMDVANAVLDGTDAVMLSAETAAGDFPVETVTSMAGVCMGAEKVPTVNVS
NHRLDRRFTTPEETIAMSTMYAANHMEGITAMITLTESGRTPLMMSRLSS
GLPIFALSRNEGTLNRAALYRGVTPVFFDEKADSGLPSTYAAINTLKSKG
LLSTGDQVIITQGDVMDIVGSTNCMRIITVE
>VF0603 PTS system, cellobiose-specific IIC component
MGTQAVNLQSTIMEKVNKFLPKILKVVNSKPIVAIKEGFMLTMPLTIIGS
VFLLLAFVPIDGYNEFMAGIFGAEWSTPLFQVVGATFDILALIGAFGIAY
TYVKYEGHNGVNAGVLAIVSLLIVMNAFVVAPDGVTQIGGVIPKAFLGGK
GMIAAIVIGLVVGIIYSMAFNRNWVIKLPDSVPEGVSNAFKSLIPGFLII
TLAFLTYIFFEVVFERTFIETIYHIIQTPLQSMSDSFFGAVGIALLISLL
WWCGVHGPVIVMGIMGPIVTANALHNQSIVNAGEALIAGENGKVVTNQFV
DQFITVGGSGLTFGLVCCMVLFARSIQFKQLGRLSFIPGIFNINEPVIFA
TPIIFNPIMFIPFVTAPVLSAIMVYTSINMGFVGPFTAVQVPWTTPMVLS
GFIVGGWSAALLQIAVFCMTVCVYFPFFKYQDKLAAQDEAKAAAPTSQAT
A
>VF0707 LuxP protein precursor
MRNGRLLLSFLFISLISFFCTSKLVLADPVLVGYWGYNEYLDLYPEEKAL
TNTLKETVRGEPVPLAIKQTKPIKISFVYPGEQSSDYWQRNIVALESRLK
ALNIQYELTPVSTRLNVDFKEQSRSLHKAIEQKSDYLIFTLNTTRHRKFI
EHVLQNPETKIILQNITTPVKAWHGSQPLLYVGFDHVIGTKLLANYFQHR
FPEHANYGMLYYSYGYLSTARGDVFVQSMDSDKYTLTSSFYTEATEESAY
AATQDILKDNPDIDFIYSSSTDIALGAIDAINDNKNTKTVINGWGGGSLE
LKAIENGELDVTVMRMTDDTGIAMAEAIKLDLENKPVATVYSGEFELVTS
DTSEETLNTLKQRAFRYSGVEH
>VFA0337 putative glucosyl hydrolase precursor
MFDEGTGFFYDIRIEDKPLANGCAGKPIVERGKGPEGWSPLFNKAATQSH
ADVVVKVMKDPKEFNTYVPLGTAALTSPAFGPDIYWRGRVWVDQFYFGLK
GMESYGYRDDAVQMASAFFDHADGLVGDGPIRENYNPLTGDQQGAPNFSW
SSAHLYMLYNDFFTAEK
>VF1620 periplasmic protein TorT precursor
MKLTFHLIYIILFSVFLSPLAHAKTPWKLCAIYPHLKDSYWLSVNYGMVK
EAKAQHVELTVYESGGYPNVERQTQQIEQCVLNGSDAIILGTVDPMAFQA
NLITLTKGIPVFATVNQLISSYPPATPVHHGEVGVDWYEMGYKTGEFLAK
RHPKDSGITYIGWLPGPKTRGGTKPVTQGFNDAIKDSDIIVSATYWGDNS
KELQRNLIQDALQTEKLDYLVGGAVAIEVAISEVASRKMQNQVGLVSTYL
SHAVYRGLLRNRVLFSPTDKMVLQGQLSIQQAVSYLNKHPLSFQLSPKIE
ALTPQHLPKKVLEESLSPAEYRPTFFVSAEKQ
>VFA1000 PTS system, N-acetylgalactosamine-specific IIA component
MIGIVVSGHINFATGVESAVKAIAGEQEQMEFVDFVESMSTDELEQALRA
AAKRVDSGEGVLFLTDIPGGSPANRALTILMDTENVELIGGANLPMVANA
AFERDDTTVKELVTTLLEIGSSCMQDMRLQLELFMEPEPECEDGL
>VFA0808 1,4-alpha-glucan branching enzyme
MQLERAAFSDPFSFLGPQYQSQTTALRVWLPGATSVKVRLSGHVEYQLLS
DPRHSGIFVLNESIDMTEVHYELIIDWSGTEQILDDPYQYHDISPTDAQV
HTPKEMYNHLGAHLFNVVRDGKQIQGVRYLVFAPNASSASVIGDFNQWDG
RRHIMQRIDNGLWALFIPEHAVGTKYKFELKGPNGESLPHKMDPYGAHNE
QYPSFASVVYDQTSYQWNDAKWQQRPVTEKQKEALSFYELHAGSWKRNEN
GDFLTYRELAEQLIPYILDMGYTHIELMPVSEHPFYGSWGYQPIGLFSPT
SRFGTPDDFKYFVDQCHQVGIGVVLDWVPAHFPSDSHGLANFDGTSLFND
PDPRRGWHNDWQSFIYNYDQPHVREFLVSNALYWFEHFHIDGLRVDAVAS
MLYLDYSRNDGEWIPNWEGGNHNHGAIALLKWMNEEVYSHYPNAMTIAEE
STAFPGVSAPTFAGGLGFGFKWNMGWMHDSLNYIREDPIHRKYHHDTITF
PLVYAFSENFILSLSHDEVVYGKGSILDKMPGDEWQKTANLRAYMGYMYG
QPGKKLNFMGAEIAQSAEWDHDGQLQWFLTQFERHSGMQSLVRDLNKLYT
TEPALYQKDCEPAGFEWRLQDEAEMSVLAHERLGDNGERILVVSNFTPAP
REDFRLGMPVAGQYELILNSDAHFYGGSDYSVISEASTEKVESQGLAQSI
VITLPPLSTVFYRLK
>VFA0235 glycerol uptake facilitator protein
MRQNKQHTLFGECLAEFIGTGLLIFFGVGCVAALVLTGAEFGQWEVSIIW
GFGVAIAIYCTAGVSGAHINPAVTIALAAFHGFDKAKVIPYIISQMLGAF
CSAALVYSLYSNLFADYEIANGFLRSSEAALSTAGIFSTYPHPSLSILGA
FAVEFVITAVLMFGILALGDEHNGASRGPMNPLLIGILIAVIGGSLGPLT
GFAMNPARDFGPKLFAYLAGWDYALTGAKEIPYFIIPILAPIAGACFGGW
AYPKMIGAYLPTAGQGCTIPNQCDKDEDSKTAEA
>VF0720 AmpG protein
MSHSMQWKTAIKSYMDKRLLWVFMLGCSSGFPWVLIGSNMSGWLKDAGLT
RAAIGYFGSVFAVYAINFMWAPLVDRVKLPFIGNKLGQRRSWIFVCQAIV
FFCTLQIAGLDPSKNLMLTSMFALAIATASATQDVAIDAFRIDTFPKSES
TKMPQASAMAVIGWWTGYSLPGYLAFINADSIGWNGVYYGMAGIVGLLMV
FTLLVGEPKTKRDELQHEAEERHNKLVGSKVAAWFTVTVIEPFYDFFNRN
GVKTACTLLLFVFLFKIGEAFLGRMSITFYKEIGFSNEQIGYYSKLIGWG
ATVFFTLLGSLINVRFGVVKGLMIGGVAMAASNLMFALIANVGPNEHLFL
ATIIVDNFTTAFSTVAFVSFLTILTGEAFSATQYALLASLGNLGRTTLAS
FSGELADYLNSWPLFFILTAVMVIPSLIMLLMLKGYFKALLDKHQSS
>VFA0106 beta-mannosidase
MSQISLNGKWILTSPAHSHLAIPMTVPGDNYHALYQAGIITNPYMGTNEN
EVQWVRECDWHLSQEFSLSPQEMSAASLILNLSRVDTLANVFINNELVLS
STNQFQRHRIDIKPFVKPGDNTISVHFSRVDEEALSRAKKLPMPIPWAVG
NNQLPHMNLIRKTQCHSGWDWGICLMVSGIYDPIYIEVVKKIELSSIETA
QIWYQGAVDLTVNVKHECIAGQAITVNFNDEIHTLISHESGETSTIFHIE
NPELWWPSGYGEQPLYSLTVELDEQTITKRVGLRQLELNNKNDEIGSAME
FVINGFPINSKGANWIPMDAMPSLESESRYRELLTSAKDANMNMIRVWGG
GQYESELFYDLCDELGLMVWQDMMFACSLYPSTDAFLKDVEPEIRQQIQR
LKDHPSIVLWCGDNEVIGAIGWYDESKNNKTTYTVNYDRLNRNIAQWIAE
EDPSRRFWTSSPCNGDMDFGDAWHNDNRGDMHFWDVWHSGKSFDAYQDIK
PRFCSEFGFQSWPSFSEVKTFVPEEDWNVTSPTFEGHQKNGRGNSIITEM
FTRYFRFPSNFEQMLYLSQVQQAIAIKTGCEYWRAISPICRGMLYWQLND
NWPVSSWSSIEYSGRWKQLHYHAKRFFAPTYVPFEETNSELRIRAVNDHR
TEAHIDGTVYWMDFNGELLGKWAVNYTIEEDGNDVIWSLSKEKFQVSENN
SFFFIEIEVNGESIQNTWFATPKLKQLTMKKAKINLIQSGTMLTLQSDNP
AFFVHLEHDGKGQFSDSSFTLLPEKPVTIEYLGDDIETLKNTLRVYDLSN
SY
>VFA0355 galactokinase
MTNLIKNVKDAFNSVLSYAPTHIVQAPGRVNLIGEHTDYNDGFVLPCAIN
YQTVVAAAKRDDNIVRVVSVDYGNETDEFDITQEITFQENKMWSNYIRGV
VKCLIDRGYEFKGADISVSGNVPQGAGLSSSAALEVVIGQTFKELYNLNI
SQAEIALNGQQAENEFVGCNCGIMDQMISAEGNENHAMLLDCRSLETTAV
SMPEDMSVVIINSNKKRGLVDSEYNTRREQCEEAARIFGVKALRDVTIEE
FNAKAHELDEMVAKRARHVITENDRTEEAAKVLASGDMKRMAVLMAESHA
SMRDDFEITVSEVDTLVDIVKNVIGAEGGVRMTGGGFGGCIVALVPPMLV
DEVKAAVEELYEAKTGLKESIYVCQATNGAGLVL
>VF2270 hypothetical protein
MKMNKYTLLAAAVSTALFSGATLAETDVALDVITGDEAAPKVEKVNGTDV
ISDGWEVHGYASMNFRMVDGETVDTEFGKPDYKTAGTHGKSTNQVEFVIK
KHTEHANGVWSDFVVRSEYGNGNSYAYSSPGSQKANTTAQFEIKETYVEI
GGLSYLGEDTSIWGGQRYLNRSASVLSGEFWKQSSGVGAGIQTKLGGNTA
GFAIVAADTDSDINSGASDRQTLTSHDLYYYGVDVGFGSLDFDFKYITQA
NVQDDDGFGASITLNSSYYGLDGWSQTAIAYGKGAAQNRGVNFGSWSGGD
DNAESIFFTSGGVVNISENWQMGSEVTYFAGLDELFSAKDLKRYIVAARP
SYKVNDNLRLEATGSYAHEEVEVGGVWGKSADAAESDIVNLELAAAFTVN
ADYFGRPQIKPYVSYILADDEASAKDIGIKDGKSETIIGVHTEIWF
>VF0667 N-acetylmannosamine kinase
MKPCLTVDIGGTKIAAAIIESGKVLRRQQIATPSSSQPEEMDKALEELLT
PFLDDISTVAVASTGIIDDGVLTALNPLNLGGLNNYPLRAVIEKITKKPT
TVINDAQAAAWAEYQTLELNMVNMAFITVSTGVGAGVVINDDLLIGANGI
AGHAGHTLADPNGPICGCGRRGCVESIASGTAIGQAGKTYFGDNCTGEMV
FKHFSQNDPNATDIVNGSAKAIANLIADLKMVLDIELVALGGSVGLAPHY
LELVQHYLAQQPSPYQTKVQHARCGADAGLIGVAHWASKIR
>VF1518 heat shock protein 70
MSSSNRYLIGIDLGTTHTVVAYTDISLGIETSPIEIFNIDQLIGPGEVAR
KPLLPSFRYHASQSQITENDLTLPWNVKAIEGEIKNAIIGEWARELGSKV
EGRQVVSAKSWLSHTKVDRTSNILPWAGADDVEKVSPIVASASYLNHVRQ
SWNYHHPDAPMELQEVVVTVPASFDESARSFTIEAAKLAGLDKIILLEEP
QAVCYDWYHHHQDTAKEILKTIPLMVVCDVGGGTTDLSLIQARFNKDELA
LDRIGVGDHLMLGGDNIDLALAHLAEQRLDSGKKMTAAALTKLIQQTRKT
KERLLSANAPESGHITLLGSGSKLLGGSRKVELTKEEVHQIALDGFLPLT
DFNDRPNQRQTAVVEFGLPYASDPAISKHLAQFLDNHKEVSAKALGWDDA
ELANHEDRAIPVGLLLNGGVFNSPLLAERSLQLLNNWKGDTVTQLSNPHP
DLAVAYGAVAYGKARHGAQLKIGGGSARSFYLQLEEKNKQPQGLCLLAKG
SEEGEEIRMTSRRFSLTLGEPVRFNLLSTTKDQLATSGMITELADSSFVS
LPPYVVTLESSKSKDELHANQKDRVEVTLACQFTEVGTIKIECVSVEDDS
QRWLVEFEVRNQASNKSANLADQVSLPPRLPNAIASIKEAYGGSKQNPNA
IKAFNKNIEKLIGKRESWDLITSRELATALLDSKKRRRRSDKHEQNWLKM
TGFALRPGFGYPADEWKISQAWETYQQGIQFESKQSWNDWWTFWRRISGG
LNQEQQETILADMAKYLHPGSLRNPKTLEEASNKSYEAMVRLAAALEHLD
VEDKMLIASWVLGHAKNGNQPQVHWWALGRICSRSPFYGSQHNLVPPSQI
SQWLPTLLEQDWKEQPMAGFAAVMMARLTGDRTLDVSDEYREKIIEKLKK
DRCPQSWIELVSSQQALTEADSKRLFGDALPAGLRLIN
>VFA0799 maltose/maltodextrin-binding protein
MKKVLSTVALCTMAALGSINASAAIEEGQLTIWVTGDKAYEGMAEVGKRF
EEDTGIKVTVSFPDKAEEKFAQVAAAGDGPDMIFYAHDRFGGFAEAGLLA
EIKPSEELKSEIVDFAWDAVEYKGKTIAYPVAIESVSLIYNKALIKNPPK
NWEEIPALDKEMMKNGQKAIMWPLRGGAYFTWPLLAADGGYAFKKTAEGY
DIKNAGVNQKGVQDAMTFIETMVKDKTISADMDYSVAESEFVKGNVGMMI
NGPWGWANIEKAGIDYGVTTLPKFHGQASKPFVGVWVGGISAVSPNKDLA
VEFFESYLLTDEGLKSLNDDKPLGAVALNSFQKQLDTDSRIAATMNNAMN
GEIMPNIPQFTTFWYSMEEALGNVVDGRQMVTDALAAAEKRMTK
>VF0506 phosphopentomutase
MKRAIILVLDSFGIGAAGDADKFGDVGSDTMGHIAEQCDKGLADNGNRKG
PLTLPNLSKLGLAMAGKESTGKFSAGLDANAEIIGAYGHAAELSSGKDTP
SGHWEIAGVPVLFDWGYFTDKENSFPKELTDRILERANLPGYLGNCHASG
TQVLDDLGEEHMKTGMPIFYTSADSVFQIACHEETFGLDNLLTLCQIARE
ELEDYNIGRVIARPFIGPGKGQFERTGNRRDLSVEPPAATILQKLVDEKG
GQVHSIGKISDIYAGCGITKKTKATGIPALFDATKEAIEQAIEQAGDNTI
VFTNFVDFDSAYGHRRDVAGYAAALEYFDGRLPEIMDMLQEDDILILTAD
HGCDPTWPGTDHTREHIPVLVYGHKVPAGSLGRRDTFADIGQTLAEYFET
SDMEYGKSFL
>VFA0388 hypothetical membrane spanning protein
MPALSVLLMDSFNYFKKHFIAFCMLVLPFALITNGIALSFNENDGPGKFL
VYMLFILTIYPFYKGAILYYIAYSFDGRRVPFSQLYQIPAKTWFSFVLMN
MILGLAILMGFMALILPGLYLMARFSFTEIYCVLYKEKTNYAIKLGWHDT
KNNYWVLFKGLVIIFGFTTGLMWALEYGLGLIGLQSPVLSFIFSISEVVL
SMMNTIFIFRVFTVNTTKLEEIQAIE
>VF0206 triosephosphate isomerase
MRHPVVMGNWKLNGSKEMVVELLNGLNAELEGVTGVDVAVAPPALFVDLA
ERTLTEAGSAIILGAQNTDLNNSGAFTGDMSPAMLKEFGATHIIIGHSER
REYHNESDEFVAKKFAFLKENGLTPVLCIGESEAQNEAGETVAVCARQID
AVINTQGVDALNGAIIAYEPIWAIGTGKAATAEDAQRIHAQIRAHIAEKS
EEVAKNVVIQYGGSVKPENAAAYFAQPDIDGALVGGAALDAKSFAAIAKA
AAEAKA
>VF1559 hypothetical protein
MNQILSFFNTLGSYLTPYLSDISVAMIACALVMLGGDINRALRAFLAGKH
FLIRTCAFIGINAFGYGLLIVKASPFLTSALRSIQPAFMLAIVFSTFIII
GIWAQKNRQV
>VFA0806 glucose-1-phosphate adenylyltransferase
MAGVLGMILAGGEGSRLRPLTESRTKPAVPFGGSYRLIDFALNNFVNADL
MRIYVLTQFKSQSLFQHMKKGWNVNGITDRFIDPVPAQMRTGKRWYEGTA
DAIYQNISFIESTDPEHVCIFGSDHIYKMDIRQMLDFHKKKKAALTVSAL
RMPAKDASGFGVIEVDEHGKMIGFEEKPSNPKCIPGQPGIALVSMGNYIF
EAESLCKELIHDAALEDSSHDFGKDIIPKMFPEGNVYVYDFSTNHIKGEK
KEVYWRDVGTIESYWEAHMDLLKKDAPFSLYNRKWPLHTYYPPLPPATFS
DSDNGRVQIIDSLVCGGSYIRGSRIEKSVLGFRSNIASACDISESILLGN
VKVGKGCVLRRVIVDKGADIAPGTEIGVNLQEDKKRYHVSDEGIVVIPKG
ERVGY
>VFA0496 Mlc protein
MYVAQPGHIDHLKQVNAGRVYKLIDQLGPISRIDLSKESNLAPASITKIT
RELLDAHLIKETQVQEANSRGRPAIGLEVDNEGWQFLSLRLGRGYLTIAL
HSLGGEQLIEERQLIKEIEQDELLAKLLNEINVFFQKHSKILGRITSIAV
SLPGLVISSQGLIIQMPHYNVKNLPLGPKIYESTGLPVFIGNDTRSWALA
EKLFGNSKNIDNSILVSIHHGVGAGIIMNGEVLQGRTGNIGEMGHIKINK
LGARCHCGNTGCLETVASAKAIRDQVKNLINNGHQTVLKDQTITIENICL
AANQGDVLAKQVITELGHNLGEAIAIMVNLFNPEMILIGGEINLSKDILY
PIIMDSIQNQVLPLYAKDTQLVESRFYTQATMPGAALVKQAMCDGSLLMK
VIEG
>VF2145 N-acetylglucosamine kinase
MTHLYVGIDGGGTSCRARIRNEQGELLGEAKSGSANILLGVDVAMNSIID
AITQATAQHNLTDADFSRMHLGLALAGAEQKSAWHNFMQQAHPFASMVLN
TDAYGACLGAHNGENGAIMIAGTGSCGIYISNGQQHVVGGREFPISDQGG
GAIMGLRLIQYTLLASDGIKPTTALTEHVLAYFENDIDSIVDWSKTARPC
DYGQFSPAIFELALKGDTLAIDMLQQTASDIEMFLTALNKKGATKIALMG
SIGERIVEWLSPSIRQYLVQPQFDAIEGGIMMARNKEHNLF
>VF2340 allosteric 6-phosphofructokinase
MVKKIGVLTSGGDAPGMNAAVRGVVRTALTEGLEVFGIHDGYLGLVEDRI
EKLERHSVSDMINRGGTFLGSARFPEFKEVAVREKAIENLKKHDIDALIV
IGGDGSYMGAKKLTEMGYPCIGLPGTIDNDIAGTDYTIGYLTALNTVIDA
IDRLRDTSSSHQRISIVEVMGRHCGDLTLMSAIAGGCEYVITPETGLNKE
ALIQNIQDGIAKGKKHAIIAITELMTDVNQLAKEIEAETGRETRATVLGH
IQRGGQPGAFDRILASRMGNYGVKLLIDGHGGRCVGIQNEQLVHHDIIDA
IENMRRPEKLELYKVAEELF
>VF0109 transporter, drug/metabolite exporter family
MNKKYLPALLFVSVCLIWGTTWLAMEFAVQTIPPIFATGLRFLIASPLLI
MLAKLFKQSLFFPKGKRLWMLIVAMFYFAIPFTLMIFGEQYISSGLASII
FANMPIAVMFTSSLFLGLKLRKIQIGGLFIAVLSLILILTKEMSLGGEDY
LLGFLALGGAVLMHAIMYVLVEKFCERVPVLTYNALPNLIASLCLLVTSM
FIEQPDVSTFSVDSIMAVIYLGIFASVGGIVAYFKLGQVSSPFTASICFL
FFPLIALSLSVWFAGNSISTTSVLLLLPLLFGILITKLDASFWTKLFSLG
MGERRKQKVS
>VF0808 hypothetical protein
MNILGYFQKVGKALMVPVATLPAAAILMGIGYWIDPVAWGGNSALAAFLI
KAGAAIIDNMSVLFAVGVAYGMSKDKDGAAALSGFVGFLVVTTLLSPGAV
AQIQGIDPAAVPAAFGKINNQFVGILVGIVSAEIYNRFSSVELHKALAFF
SGKRLVPILTSFAGILIAFVLMYIWPAIYGGLVHFGESIQGMGSVGAGIY
AFFNRLLIPVGLHHALNSVFWFDVAGINDIPNFLGGAKSIAEGTATVGVT
GMYQAGFFPIMMFGLPGAALAIYHTAKVENKEKVASIMIAAGFASFFTGV
TEPLEFSFMFLAPALYVVHAALTGISVFIAASMQWIAGFGFSAGLVDMVL
STRNPLAVNWYMLIIQGIVFFAIYYFVFRAVIVKFNLKTPGREDDEDEEG
STVGGSKETGELAKQYLKALGGHENLENIDACITRLRLTLKDTSVISEKQ
LKALGAMGVVKLGSNNVQVILGPLAEIVAGEMKKIPASEDLTAVALP
>VF1598 exochitinase
MFKKKLGLCSAAVTLALSAPAFAAAPGQAIISWMETDFSIIEIDQAATSY
KSLVTVKDFAEVPVTWDRWSGESAEKWRVLLNGVVVHEESVSPAASQKAS
TTLQVRQGGQYEMTVQLCNGSGATEECSTSAAKSIVVADTDGSHLDPLPM
NVDPANGNYTTPAGMVSGAYFVEWGVYGRKFAVDQIPAQNLTHILYGFIP
ICGPNPSLGEIENGNSLAALNRACAGTPDYEVVIHDPWAAVQMPQPQSGH
VHSTPYKGTYGQMMALKQRYPDLKIVPSIGGWTLSDPFYDFVDKSKRDIF
VASVKKFLKTWKFYDGVDIDWEFPGGDGASATDGDPVNDGPAYVALMQEL
RAMLDELSAETGKTYELTSAIGAGYDKIEDVDYAAASQYMDYIFAMTYDF
YGGWNNVVGHQTALNCGSHMSQGECDGTGLDDKGEPRKGPAYTTSNAIDL
LLAQGVDAKKLVVGAAMYARGWTGVTRESMTDPTNPMTGVGNGKVAGSWE
AGVIDYKDVVTRYIDKAGVEVGYDEVAQAAYAYDPSNGDLVTYDNKRSIL
AKGDYVRSLGLGGLFAWEIDADNGDILNAMQEGLAGDGTVTPPANKKPVA
NAGVDVSVIAPAFVQLDGSLSSDSDGSIVSYAWTQVSGPNVTLIGADSVN
PSFATDTFTQSETLQFTLKVTDDKGATASDSVAVSVTVEGTEPVNNPPVA
VIVAPTSVNKGDVVTLDASTSTDADSDPLTFTWVVPTGVDATVIGSQVTF
TAASYPVDTPFTFSVTANDGQASDTANVTVTVLKDAGDPPVTCDNAWDAS
TVYTGGDQVSQAGKVWEAKWWTKGDEPSKSGEWGVWKEVGISTCN
>VF0316 transporter, drug/metabolite exporter family
MSMRSMMAPTHLAIILLILGNLLASLSDVAVKVLDGGVSPFQYIFLRQLI
SLALLFPFWFHQQPKLRCLSNPKVTLIRAHVLLIGSGCMVVSITYLTLAT
ANAVFYTAPLLMIPLSILLLNEKPSTKKIFQTIVGFLGALIILRPSQFHW
AAIFALGTATTLALYNILVRKIPNDQSVITTLFWTTLLSLPVSGGLAWLY
WQPLHYHEVLWIALSATFIISYNGLATIAYKKAPATQISLAEYSGLIFVV
IFGVIWFDEIPDILTAVGIALIVIPLMPKT
>VF1719 PTS system, glucose-specific IIABC component
MQQKANKTTLWEFLQSLGKTFMVPVALLAFSGILLGIGSSFSSAALKEAM
PFFDNVILQYIFIWMTKIGLVAFIYLPVMFAIAIPMGLAREEKGVAAFSG
LVGYAALNLSINFYLTVTGALDSEALRQSYGVTSILGTESIDTGILGAVI
VGIIVAKLHTRFYTFKMPDALAFFGGARFVPIISSLTLGVVGLLVPFIWP
YFAAGINGIGYAIAGAGDFGPFLFGAGERLLLPIGLHHILVALIRFTEAG
GTMEVCGDTVSGALNIFYSELSCPDTQGFTPSVTAFLSQGKMPAFLGGLP
GAALAMYHCSKVENRSKIKALLISGVVACVVGGITEPLEFLFLFVAPVLY
FIHAMLTGLGFMVMGMLDVTIGNTDGNIIDFLVFGVLQGTATKWYLVPVV
AGVWFTIYYFVFKFAILKFNLKTPGRETNEVPVSAEAETILATEGGKGAL
ILSALGGAENITSLDNCITRLRLTVADMRLVNDAELKAYGALGVVKLDEH
SLQVVIGTQVHMVKNEIQSLMATPA
>VF0041 chloramphenicol resistance protein
MHTPVTPQSATSMSSVSDKKIITLMVVLVLFSPLAIDIYLPALPAMAAEF
HVPSTMAQDTITWFMFSMGLGQLFAGPLADRYGRRPIALTGIVIYGLSAV
LAYFAQAMEMLLLARLLQGFGACATSVAAFASVRDSFGAEKGGRMISYLN
GAICFIPALAPILGSYLTHHFGWRSNFSFMAGFALVGFALILTNYKETKP
ENTVQTGKLISPSRYWSVLKNPTFLFHASLCMLSMGVILAYVTSAPVFLM
DQLGLTMNEFTYWFAINAAINIAVCFIAPKFMIKFGTKRVLLSGLTILAI
SGGLMLGMQHIQQAWAFMVPIFLASVGYASVLGSAAGKALAPFGDRAGTA
AALLGLFQMSGAGIIVGTMQRLALPSAQLLTLMMWFLIPGLLILLTKTGQ
RWHSETVTQ
>VF1897 PTS system, glucose-specific IIA component
MGLFDKIKSAFSSESADAGAIDIIAPLSGEIVNIEDVPDVVFAEKIVGDG
IAIKPAGNKMVAPVNGTIGKIFETNHAFSIESNDGIELFVHFGIDTVELK
GEGFTRIAEEGQEVKAGDTIIEFDLAVLEEKAKSTLTPVVISNMDEIKEL
TKLSGAVTVGESPVLKVTK
>VF0605 6-phospho-beta-glucosidase
MKFAHDFLFGAATASYQVEGAWDQDGKGPTNWDEFTKIPGKTFEGTNGDV
AVDHYNRYKEDIALMAEMGLESYRFSISWARIFPNGTGEINQKGIDFYNN
LIDECLKYGIVPFVTLYHWDLPLALEKEGAWLNKATGDAYVEFAKLCFNE
FGDRVKHFITFNETVVFCALGYMAGAHPPGIQNDPKKYFQATHNVFYAHA
KAVIEYKKLNQFGEIGLSHVFSPAFGVDDSEESHFAAMHANQFSMNWFYD
PILLGKYPEYVVKQLQEEGNLPDWTDEELQTIFEAAPLNDFMGLNYYQPQ
RVEKIQGDVEARTITRENSTGSPGNPSYDNVYRTVKMADKKYTKWDWEIS
PEGFVGGLEMLKEHYGQIKLYITENGLGDEDPIIEGEVCDIPRINFIKEH
LGAVKEAVRRGVHIKGYYAWSAIDLLSWLNGYKKQYGFIYVDHQNGLARK
KKASFHWFKDVIATRGEDI
>VFA0153 multidrug resistance protein D
MQKSYSLATFSFLIVILVAVGQMSQTMYVPSIGYMASEFKVSPASLQAVM
AVYLIPYGLSQFFYGPISDRVGRRVVILSGLALYIAGTLVALFAHEYALF
LAGCFVQGLGIGAAGVMCRTVPRDCYSGDELHRTNSIISMCMMFSPLLAP
VLGGYLTEAFGWRSSYLFLALFSIAVMIIMVTSMKETLPLEVRRKDAVWK
SYRHVLSEHRFQGYLICLVATFAGVAVFEAAAGVLLGGKLKLPATTVSIL
FILPIPGYLAGAALSSVIAKHWSEKKSLDVGLVSIVLGAAIVLIPGLMGL
TTALTLIGGAVLYFLGAGILFPAATTGALSPFPYHAGTAGALLGGMQNLG
AGLATMVASFIPADSQMPVGLIMFLMALLAVYGLRKVHSIPPSSEMPLAV
>VFA1159 bicyclomycin resistance protein
MDNKKQSIPYIWLAGLSMLGFLATDMYLPAFDIIRGDLGTTENMIGLTLS
IFLLGMAIGQLFYGRLTQKLGTKKSLIVGLSIFAISSLAASFSTSVEMLL
VARFFQALGACSANVIWQAMVIQRYDAKTSQRVFATIMPLVALSPALAPL
LGAAIEKFYGWSMIFVTLTVIGVGLALRTFVDKEPKQEKMTSEKSITFRD
VIKSKKFTGNMLIYAASSAIFFAWLTGSPFVMTQMGYSGADIGLSYVPQT
IAFIVGGYGCRWALERFDAQQVLPWILKLSIASVATVFLVSWRMDVSSII
PMLIPFCFLAAANGAIYPIVVNNALVDFKEGSAVASGLLNFLQMLFCVAA
SAMVSSISYLGAISMGSIMLLQLVFLFIGAVMVFKVNKEERAALATQ
>VF0980 transporter, MFS superfamily
MEQTTSTQSQSGLLIPVIALSLFAIASGYLMSLIPLMLSQYGIEAKYASW
LASAFYAGLLVGAGVIEPFVARLGHKNSFVLFLALLAATIIALPAIPDEL
FWMVARFVAGIAVAGVFVVVESWLLIGDAESRPKRLGLYMGALYGGSSLG
QLGIGFIGIEGLLPYYMIIGLIMMAIACLLFGKGAQPQVQHHNVLNFKQI
LKLNKASIMGCVVSGLLLGAVYGLMPLELKHRNINTAQIGSLMALIVLGG
MAVQPIVSYLSKHFAKTLLMALFCILGVFSVGLTALSDHAAVLAVALVLL
GMAAFALYPIAISLGCDQLDESYIVSATQVMLFSYSIGSVCGPVMANTLM
NTAEGLMSYLFAILLATAIYMIFANIRQHRPMVAGE
>VF1408 glucokinase
MYYGFDVGGTKIEFGAFNEKLERVATERIPTQTENYSLLVDDIASLIAKY
DAEFGVEGKVGLGIPGMEDAETGALLTSNVPAAKGQFLRKDLEAKIGRSV
KIDNDANCFALSEAWDEELKDSPSVMGLILGTGFGGGLIFDGKAFSGYSH
VAGELGHSRLPIDAWFHLGENAPLLECGCGNKGCIDNYLSGRGFELLYAH
YYGEQKKAIDIIKAHAEGDANAVEHVDRFMELLAICFANLFTCFDPHVVA
LGGGLSNFELIYEELPKRLPKHLLSVGRVPRIIKAKHGDSGGVRGAAFLN
IKD
>VF0195 UDP-N-acetyl-D-quinovosamine 4-epimerase
MNILLTGGFGFIGQQVVKLSPIKRKVVRMGESYSGSSVHQIDTLSTTTNW
QGAFTDINAIIHLAGLAHSNSFSEQDYQEVNVDGTLHLANEAAKSGVKRF
VFVSSIGVNGTSTYQTPFSSLSKVEPHSAYAQSKYDAEVGLQKIAEETGL
EVVIVRPTLVYGPNAPGNFGALTRLVNKVPVLPFGLVNNKRDFISVQNLA
DLLITCANDPKAAGRTFLASDGQVVSIKDFTNAIAKGLNKRVIQLPIPVW
CMRLAGKLLGKEVMIEQLVGNLEVDSSNAQEVLGWIPPYTMQQAMHSLLE
NNK
>VF0606 glucokinase
MATYISFDIGGTDIKFGVLNEQGKVLEQGKVKTETCGEKIIATLVDIKEQ
WSKKYTFDGAAFSLPGFVDVNTGYLKTGGAIDDFYGFQFKDELTKKLSLP
VELENDVNCVALAEKWLGKAQHVENFICITIGTGIGGAIYINNQMVRGHG
FMAGEFGYMFTRNVFDIEDKATASMSFTASVREGLRRRYSTLKNINSIDN
ISGKDIFELASTGDEVAIKVIDDFYNNIAIGLYNLTFILNPEKIIIGGAI
SSREDLISNIEKKFNQIIKSQSSINEFNVKELVSIEKSTFNNDSGLIGAV
YHFLTMKNKFK
>VFA0940 PTS system, fructose-specific IIBC component
MKNIAIVTACPSGVANSIIAAGLLEQAAKKLNWTASIECQSSVLPVDVLS
QEVIDGADAIIIAANTEVDTARFVGKKVYTGTISECTTDTQAWLENAANS
AKELTASEVTSIVVADDTGAKKIVAITACPTGVAHTFMAAEALEEEGKRQ
GHIIKVETRGSVGAKNQLTDQEIAEADLVIIAADIEVPLERFNGKRLYKT
STGLALKKTEQEMNKAFADATVFQASGNTQSSQTEEKKGMYKHLMTGVSH
MLPVVIAGGLLIALSFVFGIEAFKEPGTIAATLMDIGGGAAFALMIPVLA
GFIAFSIADRPGLAPGLIGGMLASSTGAGFLGGIAAGFIAGYSAKFIADK
VSLPQSMEALKPILIIPFVASLFTGLVMIYIVGGPVSGIMSALTEFLNNM
GSTNAVLLGVILGCMMCFDLGGPVNKAAYTFGVGLLASQTYGPMAAIMAA
GMVPALGMGLATFLAKNKFEAGEREAGKASFVLGLCFISEGAIPFAAKDP
MRVIPSCMAGGALTGGLSMLFGAQLLAPHGGLFVLLIPNAITPVFMYLVA
IAAGTAVTGFTYAFLKNKADAKEAAAA
>VFA1139 hypothetical protein
MKNKLTLTLMELQGIPAEKGNNLTLAILTHSDIDSFDALFRNLKNRYFPN
AEIYFSVSSDEIYLRGEDRNASIKNEYHKIKECIDNMTKGVEILVCDRNL
GFAQDFPVFDNADELDLTKKDKSPSWILISDESSLGGLYDECPESITFKV
GGDSNNVRTITYCKKEEKPILTSIVTAAHLIYSNESAYREQLHDLPPSKE
YAESELKHLVNSLQS
>VF2357 glucosamine-6-phosphate isomerase
MRLIPLNRAEQVGAWSAQHIVNRINAFNPTADRPFVLGLPTGGTPLNTYK
KLIELHKAGEVSFKNVVTFNMDEYVGLPADHPESYRTFMHENFFNHIDIQ
PENINLLNGNAEDHEAECQRYEDKIKSYGRINLFMGGVGNDGHIAFNEPA
SSLSSRTRIKTLTEDTRIANSRFFGGDMNLVPEYSLTIGVGTLLDSEEIM
ILITGHNKGLALQAAVEGSVNHLWTVSALQLHPKSVIVCDEPSTQELKVK
TVKYFQQLEAKNMEGF
>VFA0611 oxalate/formate antiporter
MKNIDKAMRILLAGFCINLCLGILYAWSVFNKALVTDMGWTASQASQPYA
TATITFSICLLVAGILQDRMGPRLILIFGTVLVGLGMIASSFAETVFMLN
ITFGIMTGAGIGFGYACLAPSAMKWFHPSKKGMVNGLIAAGFGLAAIYLA
PVTSALISMYGIQTSFLVLGVAILIIAVPLATTINNPPEGYQPEEPKVKA
GKAPVTTRKPMDLNWKAMLKTPQFYSLWIMYAFAASAGLMIIGNITTIAS
MQANLPNAVYLASLLAVFNSGGRVAAGMLSDKIGGVKTLLIAFVLQGANM
ALFSMYDNEVMLIIGTAVAAVGYGTLLAVFPSLTAEFYGLKNYGTNYGVL
YTSWGIGGAIGAAVVGFSMTQGGDYALAYTISAAMVGVAIILALVTKPIS
EEKAQQLSPATV
>VFA1001 PTS system, N-acetylgalactosamine-specific IID component
MVSKTENPNALIDGIDEFQGTQVANPKSLVDGIDEYQDKEVRKVISKKDL
WKCAIRGLFMEGNFNFERMQGGGFAYSIVPALKKIHGNNKRDLATATKNH
LQFFNASPKLFTFLLGTAIAMEENKEKPSTVNVMKVAGMGPTGGIGDAID
HMTLMPLTLALGASIAMQGSIAGPFVFFILYQIVHFFVYFGLMFMGYKAG
TAAMVNMSDATEKLAKAANIMGIFVIGALSASFIKVQTTLSLELGGKVVE
LQTALFDKIMPNILPLALVFFMLKMVKGTGFWAKPPVLIFSTLAGGVIGH
YLGIL
>VFA0028 sugar efflux transporter A
MYKDKTSLLFIFTAFITGLCSAFFYPLSSLFIVEELDASPMMLSLYMTLA
VSSSVIVSQFIAKRSDTHWNRKTILMISLASYLILVASFTVIRDYWLAIT
MAVVFGSVSGASFGQLFALGREYGDRHVTNSTSFLATMRAGLAIAWVFGP
PAAFMLKAQFGFSAAFAVSAITVSVAILIIAKFIPDNVVTKEEKTAAITE
HKPLGRIVILYCFIIVCAFSANNLYITSMPLYLSQELQVDVSWLGLMFGV
AAACEIPVMLGAGKMAEKMGTTRVMTLGVISGAMFFLVMLSSTSFTSMLI
AQILNGFFIGVCATLGMVALQDMMKDRLGTASTLFSNMLNISVLVSSVLV
GVVGELYNYYSALYLCFIGAIIAAVLLIVFEVLEKKQKVKIEGQCEMVG
>VF0354 hypothetical protein
MFFISIIVFLVIANGFAIISEHFLSYSHMETIIRLFNVDKEMNVPTLYSS
CAMIFASVLLALIAYVHFNKNEQYLAWAGLSAIFLFLALDEMTELHEMLV
GPVRNSLNTTGILYFAWVIPYAALLLVFGLTYFKFLFRLPTNTRNRLILA
GIIYVSGALVMELIGGKIAEQHGTDALIYAISYTIEETLEMLGIATLIYT
ATTYISEQFPTLSVQIKD
>VF1895 phosphoenolpyruvate-protein phosphotransferase
MISGILASPGIAFGKALLLQEDEIVLNKTPISDSQVETEVQRFFDARNKS
SEQLEAIKAKALATFGEEKEAIFEGHIMLLEDEELEEEILALIKDDKMAA
DFAIHSVIEEQACALESLDDDYLKERATDIRDIGSRFVKNALGINIVSLS
DINEEVILVANDLTPSETAQINLDYVLGFACDIGGRTSHTCYHGAFS
>VFA0338 putative glucosyl hydrolase precursor
MNLKISALAVATALFAVGCTQTTSTTNTSDLKAAQYKNVIDRTGSPDYMR
DYDFDNHQRFNPFFDMGAWHGHLLPDNDDGMGGFPGTALLTEEYINFMAN
NFDRLSVYKDGKKVEFNMEAYSLPGALVQILTSDDVTIEMTLRFATNRTS
LVETKIITNTPVELIWDGQLIEGNHAKEEKSQSEKTIAEEYPNYNRTIVP
TDDGLKVTFGKVRATWSLLTSGESEYQIHKSIPTTTKVEGLSFNSTARIE
QSTTIYTTYSHVLTAEENQEEQIKILDIFAHPQQYLTASEQRWENYLEKG
LTNPNATPAQERVAVKAMETLNANWRGAAGAMQFDSVTPSVTARWFSGNQ
TWPWDTWKQAYAMAHFNPEVAKNNIRAMFAYQIQADDAVRPWDKGFIPDL
VAYNTSPERGGDGGNWNERNTKPSLAAWAVMEVYKTTEDKAWLEEMYPKL
VAYHDWWLRNRDNNGNGVPEYGASRDKAHNTDNGDMLFTVEHGNKKEELA
GLDKYQEIIKSGNYDHIKIPAQTAASWESGRDDAAAFGFIDKEQLDAYVK
NSGKRSDWEVKFAQNRDKNGTLLGYSLLQESVDQASYMYSDNQYLAEMAD
ILAKHLKQKTLRKSR
>VF2360 glyceraldehyde 3-phosphate dehydrogenase
MKIKVGINGFGRIGRLALRAAFDWPELEFVQINDAAGDAHTLAHLLEFDS
VQGRWHHEVISNGSDMIIAGQTLKTTQEKDIDAVDWSGCDVVIEATGVHR
KRVFLDKYLAQGVKRVVVSAPVKEEGVVNIVVGVNDDIFDPAVHQIVTAA
SCTTNCLAPIVKVINKGLGIENAAFTTIHDLTNTQTILDAPHKDLRRARA
CGMSLIPTTTGSAKAIVEIFPELKDKIDGHAVRVPLANASLTDIIFEVKR
DTTVEEVNQLLKDAAQGDLKGILGYEERPLVSIDYKGDQRSTIVDAPSTM
LVGKRMVKIYAWYDNEMGYATRTAELVRNVGLA
>VF0655 endochitinase
MKGIFIKSAIASALFISYGANAFDCSSTPIWQSTQAYSGGDTVQQNNIAY
QAQWWSQGNDPETHSGEWQEWKNLGKCSTGGENIAPTVTIISPINNAIIP
EASLITLQASADDKDGSITQVEFLSNNQSIAIVTSPPYNTPWIAIKNTTS
IIVIATDDEGATTTESVSIKVQSAGELVPPTIELTSPIGNEKLTTGDTLV
VSANANDSDGVINNVEFYIDNQLAFTDTEAPFEYSWLATSGPHQFKAKAT
DNDNQTTISKGVTLEVSEPSSGGCAGLPQYKSGTNYAAGDEVQNLNQKYR
CDIGGWCSSSSDWAYAPGTGSNWQDAWTGLGVCSTPPQVTITSPNDNSVI
LAGSIVEVNASASDSDGSVIGVEFFANNVTLGSDTQAPYTVNWDATVIGS
NTLKAVATDNEGNNSENSILVTVSDQNVVTALTSPITGSSLVLGKITQLK
ATATSLSSSITKVDFLVNGVIIASDTTSPYSVNWTPAAIGAYTLSVEATD
AQGNTALSTASSVSVVEQTLAKHKLIGYWHNFVNGSGCPIRLADMSDEWD
IIDIAFADNDRNSNGTVHFNLYSGDIHSSCPALDPTQFKQDMAALQAKGK
VFVLSLGGAEGTITLNTDNDEVNFVNSLTAIIDEWGFDGLDIDLESGSNL
LHGTQIQARLPTALKQIEANMGGDMYLTMAPEHPYVQGGMIAYSGIWGAY
IPVINQVRDTLDLLHVQLYNNGGLPNPYMPGSAPEGSVDMMVASVKMLVE
GFELADGTFFAPLRDDQVAIGLPSGPSSANSGQAPIQNIVDALDCVTYGT
ACSSVVPSKLYSNFGGVMTWSINWDLHDGFNFSKPVGDKLNQMNNQ
>VFA0369 PTS system, fructose-like-1 IIA component
MITSLVNTDLITLDLKSTTKDGVFSELAETLLQNGRINNKENFLTDIYTR
EAQCVTSDMGIAYPHAKSPSVITPAIAVGVSKEPIEYQADDEQPSVFFMI
ASPESGDHHIYALQALFEKFGDDLIADMQKATTKQQILDLLTN
>VF1445 ribose transport ATP-binding protein RbsA
MTQAILELNGIEKAFPGVKALDGACLNVYPGKVMALMGENGAGKSTLMKS
LTGIYAMDAGEIRYEGKAVNFNGPKHSQESGISIIHQELNLIPELTIAEN
IFLGREKTNAFGGIKWSEMYKDADALLKRLNVKHHSRQLLGELSLGEQQM
VEIAKALSFKSKVIIMDEPTDALTDTETESLFKVINELRDEGCGIVYISH
RLKEIFEICDDITVLRDGKFIGERVVADIDEDTLIEMMVGRRLDEQYPRI
DVQHGEKSLELFDVSGPGVHNVSFSLDRGEILGISGLMGAGRTELMKIIY
GALPMTCGAIKLNNKMINPISPRDGLANGIAYISEDRKGDGLVLGLSVKE
NMSICSLDQLSKGIQLDHHAEVTAVEDFIRLFNIKTPTRDQIIGNLSGGN
QQKVAIAKGLMTRPKVLILDEPTRGVDVGAKKEIYQLINQFKAEGMSIIL
VSSEMPEVLGMSDRILVMHEGRISGEFMAKDADQEKLLACAVGKTVEQNV
EVTA
>VFA0801 isoamylase
MNTHQAFPFPLGATLTNTGCNFAVHHDSAFPLSLIIFKEDGSYTEHSFTE
EYGTIKYTHLTGIKEGAVYGFKIIKNEEDLLLLDPYAKALKNIPNYQVPY
TAKQSWSLAQAIVVNDNFDWQSTTMPIIPRSETILLETHVKGFTLLNPNI
DENVRGTYLGLVDPATIAHIKEQGITSIQLLPIAACMHEPHLLEMGMVNY
WGYNSLSFMAPDPRYAISDAVTELKTAIRELHKNNIEVILDVVYNHTAEG
GNGGCTFNLKGLDQDYYLHHNGNYTNYTGCGNTLDITHQPSLNLVMDTLR
YWVEHYHIDGFRFDLAATLGREYDQFNPNNAFFKAIAQDPILKNTKLIAE
PWDIGPNGYQVGEFPDGWNECSDKYRDTTKSFWRGEQNYLKSIATRLMGS
RDLVSASRWPHKLPVNYVSYHDGFTLQDLVSYKNRHNHANGENNRDGHGD
NRSDNYGVEGPTDNPRIIALREKQKRNMMTTLLFSFGIPHLLAADACSHT
QQGNNNAYCQDSEISWVNWNLDPTAQEFKIWLSDMIHARQKHIVPIINAF
SGSKRSHQKVEWYTPDGRTMTHNDWHGAKSLCLHLNIYDGEKELLIMINQ
SNIPTRFVLPKLTKQANWSLVCDTQYSKVKPKPIVFDYSLSPLSIAVFCN
K
>VFA0706 diguanylate cyclase/phosphodiesterase domain 2 (EAL)
MFKRKNSQSSSRSYIYDLSAIALLLLPLTLSNATAVLLGHLFNFFEFKEL
SSLLFHLSNLLINIYPLSFCVIAGYYLSHKTTFSSATFIIYALALFYLLS
IENGSLSTPFYFPNNPLLALLSALITFMYCTRFNLQQLEPQALDFSSRLF
KHVFHFFTFISAAFLLSKLMMKVINYMTALIGNMSADPLTFTGGLIYQTI
LGLLGAIGINGHNMLFAVKQTIYSETQQNMADWAAGEATLNIINQGFYDA
FMSMGGSGNSISLLLCILLFSKEKNHIMLALAAFPLVMFNINEVLLFGLP
IIFNPLLIVPFVALPLISFLITYLAIFSGAISPVVNIVNWMTPPLFSGYV
AMGESIEGSILQLVIIIVGIFVYRPFYLAFAGKYALNHPAVLSNTNIEQS
IFKSLLDNVRSSAATSLKHSSTQQRLSRMLHEDGFVMHYQLLQSVVEKDV
ISFEALLRYQDREGNLCPPTFISDFQLLNMMPTLDKLVIDKVLTDMQKMD
LNEDRRVAINISVASIEEHGFAEHVIDRLKFFSIPPHWLEIEITEEAILS
DNHNLLSTLEILKSHGIKIAMDDFGTGYASFPHLLKYPFDKIKLDRSLLL
DASTTKGKQLYQLIAQMGDVANCEVVAEGVETEDEFKFVAECGVDKVQGF
LIARPQPLSEALKLIKRNDQIDTNRNK
>VF2358 transporter, MFS superfamily
MFSQLSHSVRQYMLVTFNYWNFTITDGALRMLVVLYFHDLGYTTLAIASL
FLFYEFFGVVTNLIGGWLGARLGLNKTMNIGLLMQVGALLMLALPSSWLT
IPWVMAAQAFSGIAKDLNKMSAKSAIKTLVPSEQEGALYKWVAILTGSKN
ALKGAGFFLGGLLLTTIGFQFAVIAMASVLFVVFVGSVLLLDGDMGKAKS
KPKFTQLFSKSEQINTLSAARLFLFGARDVWFVVALPIYLGSVFNWDHSL
VGGFLALWVIAYGFVQGFAPKITGKAEGKVPDGRAAMWWVSLLALVTGII
AYSVQIEWQPEYVIVIGLLIFGGIFAVNSSLHSYLIVSYAKGDGVSMDVG
FYYMANAMGRLVGTILSGWVFQVAGFAACLWVSFGFLLFAALISIKLPKS
D
>VFA0631 hypothetical protein
MLNQLLERAQCYDIETKVEGITNHLPMALIALDRLGATPERLDEYFLSYS
EKLKPFQCSAYDQDFNWLEHLGDKDKFNVYLSFYFDQISLLGIKLALSKY
INRLIQGCAASAFHALIRLSYGIIQENHKEIAFGLAHMSSHFMPLPVPIQ
VNTKPESVINNALRAFSKYVAVGDSVTKRITDISTKPEYSSVNYYPAGLT
LRACSKLFSKLYLQSHDFTVLHTVTSCHAMRVLLPYIDDKDTALKSYWSA
SLVAILSIKDLKFNLIIEGEYLGNLDVQTVINSNNDHTIKLVFSCIEEYK
HYNDVNYLKILSSKLKA
>VFA0370 PTS system, fructose-like enzyme IIC component
MSTMTATHNQSDWKQTLSKLKGHLLFGTSHMLPFVVAGGVLLALAVMATG
KGAVPDTGILADISTIAIKGLVLFPIILGGFIGYSIADKPALAPAFIASG
IMADLGGGFLGCIVAGFIAGGVVLQLKKLPIPAHLSALGVYFIYPLVGTL
VSAGIVMWGLGAAISSFMVGMNEFLASMAGSSKAVLGAILGGMTAFDMGG
PINKVATLFAQTQVNTQPWLMGGVGIAICTPPLGMALATFLFKKKFSKEE
QEAGKAAAIMGSIGISEGAIPFAANDPVRVLPSIVIGGMVGCVFGFLTDV
LLHAPWGGLITAPVSSNIPMYVVGIALGSLTTALIVGFWKPVVIEEDEVV
VAAPSETQAAAPVAGEGEYDVLAVTCCPSGVAHTFMAAKALEKAGAAAGI
KIKVETQGSNGLMNKLTAKDVENAKFIILAHDIPVKEAERFTNIRQVECS
TKGAMKTALSLIQDNLK
>VF0982 transporter, drug/metabolite exporter family
MSYLLSITLLWAFSFSLIGVYLAGQVDAWFSVLMRIGLATLVFLPFLRPK
NISLNTALKLMAIGAIQLGLMYVFYYQSFLYLTVPEVLLFTVMTPIYITL
LNDAFEGKFHSHFMISAVIATLGAIAIRYNGIDAGFLLGFGLVQGANLCF
ATGQVCYKRLMKDQEIEQKTVFGFFFIGAFIVASTCYLLFGNSEKLPTTS
VQWGVLIYLGVIASGMGYFMWNKGATLVNVGVLAVMNNLLIPAGILVNLL
IWNRDADILRLSIGGALILLALLVNQKLEKRHHQS
>VF0202 phosphoglycerate mutase
MSAKKPMALVILDGYGHRETQADNAITNANTPVLDGLMANQPNTLISASG
MDVGLPDGQMGNSEVGHTNIGAGRVVYQDLTRITKAISDGEFQQNETLVN
AIDKAVKAGKAVHIMGLMSPGGVHSHEDHIYAAVEMAAARGAEKIYLHCF
LDGRDTPPRSAENSLKNFQELFAKLGKGRIASLVGRYYAMDRDNNWERVQ
KAYDLMTEAKAEFTFATAVEGLEAAYAREENDEFVQATEIKAEGEESAAI
VDGDAVIFMNYRADRARQITRTFVPSFDGFTRNVFPAIDFVMLTQYAADI
PLLCAFAPASLENTYGEWLSKEGKTQLRISETEKYAHVTFFFNGGIEDEF
EGEERQLVASPKVATYDLQPEMSAPELTEKLVAAIKSGKYDAIVCNFPNC
DMVGHTGVYDAAVKAVESLDECIGKVVEAIKEVDGQLLITADHGNAEMMI
DPETGGVHTAHTNLPVPLIYVGSKAVEFKEGGKLSDLAPTMLALTDTAIP
AEMSGEVLFK
>VFA0206 transporter, MFS superfamily
MDKSKTIEEIKQIDSVLQWNRLSRFNHMIWTVLTGTLLARTTYFMAWPFL
IVILYQDFNARAVTVGAILAGSAVVGSFTGLYSGWLSDKFGRKWVMIWGC
IIAAFSYAGIGIATSIFQLFILVGMCGLMRPMIEAPAKAVIGDNLDDEKD
RELALNVRYFLINVGGAIGPLIGITLGLAHPKVLFLITGVTYLAFGLFLF
ISFAKSNSEILLSKATSDVTSFLSTVRIISKDRLFIKLLAANVIMMFVYG
QYESSIPQVIVRTDIVDAAKFVSGLVLVNTLTIVVLQFPMLKLLENIPLF
VRTRIGMALMALAQLAFLLVPVDFPTGWLMACFILSVGEVIAFPTLNVQI
DQLAPKHLRGSYFGAAAIYGLGFALAPLVGGLLIQLGGATPLFIACFVLS
LLMIGLYKWAEREVPS
>VF2046 maltose/maltodextrin transport ATP-binding protein MalK
MSKISLRNINKKYPNSDTYSVSNFNIDIEEGEFIVLVGPSGCGKSTTLRM
IAGLEDITEGEFIIDGKVVNSVSSKDRDIAMVFQSYALYPHMSVRDNIGY
GLKLRNYPASEIKDHVDNISKDLFLTEYLERKPKELSGGQRQRVALGRAM
VRTPKLYLMDEPLSNLDAKLRTTTRTEISRMHRDKGAITIYVTHDQVEAM
TMADRIVLMSMGEVQQIGTPKELFTNPKNSFVATFMGMPSMNIIEGVYEG
GQFTCHSFTITLSEEDQRILNNAGYNGKSVCLGARSSAIRSGKKYEEAFP
DCCFETTALNSEYLGDSVNVFFDAAPMNMFAGTLGTGEPDVEIDEKITLV
IDNTKLHFFDSDTQESIKYPIKVAEFQK
>VF0209 fructose-1,6-bisphosphatase
MKRDLAMAFSRVTEGAALAGYKWLGRGDKNAADGAAVEVMRTLLNKTDIS
GEIVIGEGEIDDAPMLYIGENVGTGGDAVDIAVDPIEGTRMTAMGQSNAL
AVLAAGEKGSFLKAPDMYMEKLVVGPGAKGAIDLSLSLEDNLVNIAKALG
KPLETLVVTTLAKPRHDEVIANMQKMGVRVFAVPDGDVAASILTCMPDSE
VDVMYCIGGAPEGVVSAAVIRALDGDMQARLLPRHEVKGDTEENRIHGEA
ELKRCEEMGVKANVILKMTDMARSDDVVFAATGITKGDLLEGITRQGNIA
TTETLLIRGRCRTIRRIKSIHYLERKDAEVRDIIL
>VFA0786 PTS system, glucose-specific II BC component
MENIFSMLQRIGRAFMLPIAVLPMAGILLGVGGAFTSGPLIDTYNLTFLQ
PGTVANQFLILCFKAGLFVFMNLPLLFAVGVAIGMANKNKETAAISAVIG
FLLFHTVIGTILGFQGLTPETTTVDGLIALGYGPVEAVGLSSLYTHELGM
FTLQTGVFGGIICGLLAAYLTNKYSNKQLPDYLAFFSGNRLVPVMTMLYF
IPLAFLFPIIWPTIFKSIVAAGEAFSAMGYIGTFFYGSGMRILNVFGLHH
AIYPLFWYTELGGVQEVAGQMVSGGQKIFFAQLADPTVTHFSSEATRTMT
GGFLPMMFGLPAAAFAMYRCADDKNKKMVKGILISAALTSFLTGITEPLE
FTFLFVAPALYAIHAVLEGLSYMLMHMLDVAVGITFSRGLIDFTFFGLLQ
GTEKTDYQWILILGPIYSVVYYFIFSFMIRKFNYSTPGRNDADNKLQTRD
SYKKNKSSELIDDIVKELGGINNIESLDACITRLRVTVKDTDIVASDEVW
RSLQAKGVIRSGNGVQIIYGTQAEIYKNQILDKYNL
>VFA0998 4-deoxy-L-threo-5-hexosulose-uronateketol-isomer ase
MEIRQPIHSDHAKQLDTAGLREQFLIEGMFQENQITLTYSHIDRIIVGGV
VPTSESVPFEGGKEIGVDFFLQRRELGIINIGQAGRVIVDGVTYDIAARE
AMYVGMGAEEISFESVDQQDPARFYLNCAPAHHAYPTRKITREEASPETL
GNQENCNVRTIYKYLHPSVLPTCQLLMGMTELAPGSLWNTMPCHTHERRM
EVYLYFDMKDDNIVFHYMGEPQETRHMVVRNEQAVISPSWSIHSGVGTSS
YTFIWGMVGENQTFHDMDHVAMTDIK
>VFA1005 tagatose-6-phosphate kinase
MNTFQHLVQRHKAGEQNGIYSVCSAHPLVIEAALSQALSDDSLLLIEATS
NQVDQFGGYTGMKPADFRDFVLQLAKSLNFPTEKLILGGDHLGPNRWQKL
TAAEAMVNADDLIAAYVAAGFKKIHLDCSMSCADDPTPLSDEIVAERAAR
LAKIAEDTAVSSFGHSDLVYVIGTEVPVPGGAAEELDTLQVTSPEAARKT
IQSHQFAFERAGVADCWQRVVGLVVQPGVEFDHTGVIDYRSEEALELSKV
VDDFEHMVFEAHSTDYQTDKAYQALVRDHFAILKVGPALTFALREALYNL
CDIEEQLIPKAHCSDLREHIEKEMCDSPEYWQPYYQGNEAQQRFSRSYSF
SDRIRYYWPDEKINQAQNTLFTNLSRNGIPLPLLSQHLSSQFRSVREGQL
SLEPKELVLDKIRQTLRSYAKACKQNKEEGVAL
>VF0607 PTS system, diacetylchitobiose-specific IIA component
MLVGEELETTVMELIINAGESKSCAMEALRAAKSGEWDKVDDLLKQSAEA
SKRAHDVQTQLIGMDEGEGKVPVNLIMVHAQDHIMTSMLAKEMIQELIEI
HRALQNK
>VF1444 high affinity ribose transport protein RbsD
MKKNTLLNSELSYVIATLGHTDEITICDAGLPIPDASQRIDLALIQGIPT
FIDTVKATLTEMQIEGVIVAEEFKTVSPQMHDELMTLIAAEEAQCSKSIT
VSYIPHEEFKIHTRESKAIVRTGECTPYANVIFQSGVVF
>VFA0469 6-phosphogluconolactonase
MINHKIFETPQDVVTTLADELKQLGEQGKPVHISLSGGSTPKMLFSLLAS
EAYAKNIQWNNLHFWWGDERCVTPTDPESNYGEANELLFSRIDIPLENIH
RIEGENEPLEEVNRFSNEMRELIPLEDGIPVFDWILLGVGADGHTASLFP
NKTDYNDTNLAVIATHPESGQQRVSKTAKVLEAAKRISYLVLGSGKAEIV
QEIHTKPANELPYPAAKIHSTLGETEWFLDIDAAARIINK
>VFA1006 transcriptional regulator, GlpR family
MMSAVERRMEIVNVVNQDGKARVEDLAARFDVSSVTIRSDLSFLEKNGYV
VRSHGAAIPNTGVIAELTVHEKRHQNIGTKSSIGYAAAQLIENGDTVILD
SGTTTREIASNLKSLEQAVVMTNGLDVAMELASASGIEVLMSGGVLRKKA
LSFSGSQAEASLKNYRFDKVFLGVDGFDLRSGITTHNEQEASLNRLMCDI
SEQVIAVADSTKFGKRSCHMIREFGNIDILVTDSDIPEEYLQGLREMKVE
VIIVEKEK
>VFA0988 2-dehydro-3-deoxygluconokinase
MKKTKITIIGECMIELSGNAFSTQTQSFGGDTLNTAVYLSRLLPHVSPYY
LTALGQDQYSSLMLKAWEKENIDCSLVLRDQERLPGLYSINIDDKGERSF
HYWRDNSAAKYMCQHLLFVPNIAKIMDADIIYLSGISLAILPTHDREILF
DVLATLKKHGATIITDSNYRPRLWKNNLDAKFWLDNLYRLSDMALVTGDD
EELLLDKPNMPEKEVADRLHALGVGHVVVKLGAKGAMWSTLEGKSGYVDG
ESVDKLVDTTAAGDSFNAAYIAAYSQGASMAESCAWGNRLASQVIQHKGA
IIPMDYLQTLITDMGQINEK
>VF1800 HIT family hydrolase
MAFQLHPRLQQDCIVLGNLPLCKVLLIKEDIGPWLILVPRIEELKEIHHM
TDEQQIQFIKESSAVAQLLEDNFSPDKINIGALGNLVPQLHIHHIARFTT
DVAWPGPVWGNTTGVIRAQSSQTQLVDLLRDKLSNISGFKR
>VF0037 hypothetical protein
MKKTLLTLSISSFLFSASSLASAPNTKLNLMPYPQSVELNSGQLEITSDF
SIYIDGYKSERIQQLALRIIQRVEAQTGLPLLTPFASSKKEATLIIDVSK
AAKNKIQDNDIDESYELTINKKQIILESDRPYGALRGAETFLQLINTSKA
GYFVPQVNIEDEPRFPWRGASFDSSRHFVTVDTIKRQIDGFASAKMNVFH
WHLWDDQAIRIQIESYPKLWEKTADGDFYTKEEIKDVVEYARLRGIRVIP
EISLPGHASAVAHAYPELMSGEGEQSYDQQRAWGVFVPLMNPINPELYVF
FDKVFSEVTELFPDEYIHIGGDEPNYQQWTDNKEIQAFIAENNIDGNRGL
QSYLNARIEKMLNKKGKKIMGWDEIWHKDLPTSIVIQSWRGHDSIGRAAK
EGYTGLLSTGFYLDQPQPTSYHYRNDPMPKGPQVDDQLHSGETFETYTWQ
KPRGKGGPRKGTLTIITDKNGDARAFTDYNGKSRAKVDIMEYTKGESFRG
HFDNFMSYTEFNLIFNNGNIKKESYQLVGNVRWPTTGEMTASSSIKNSVI
PAPNGGYPVALNKDEEKLILGGEAAIWAENYDDLTVEGRIWPRTYAVAER
LWSAEELTDEDSMYQRLQAMDSWATISVGLQHQTNSYKQYLRIANGGDVS
ALMSFANYAEPAQYYARNWAKYNSTDPKGELYNQYERLNRFADAVPVESF
AVLEMIKLAKTAINDQSDLKALQKHYQTVLESAQKSEVMFKNNVSSLDTV
LLAQKHVEVAKATLAVINELEKGQQPTSTQLDKLLSITTNASGMYDEMIV
AIVRPTEELVRQLRK
>VFA0493 anhydromuramoyl-peptideexo-beta-N-acetylglucosaminidase
MGPLWLDVEGYEIDAEERELLQHPTVGGLILFARNYHDPKQLAALTASIR
KAAGRPILIGVDQEGGRVQRFRDEFTLIPPAQAYAEMDNGLELAKTAGWL
LCAELVAHDIDLTFAPVLDNGFDCKAIGNRAFGDDINTIVKYSTAFMQGM
KSAGTSTTGKHFPGHGGVIADSHLETPYDNRNNIFELDMAIFKAQIEAGI
LDAMMPAHVIYPEYDSSPASGSSYWLKDVLRKQLSFNGLVFSDDLSMEGA
TIMGGPAERSQQALDAGCDMVLMCNNRKSAVEVLDNLAIQSVAKADALLK
TQHFDRKTLLGTREWKEANELITRAYDGWKS
>VF1046 hypothetical protein
MLAKLGVRNLKGLDINRQFNMILRAISAIILLLVPIYFGYLGKTTEMGLL
IVSGFLGLVFSSLDKFESFKAGGVEAKLRYEQIKAVLEKEIEPEYSNETE
SSDINNPNLKLVPENAQSVLTALNNSDYTWRYVSGISQSIKLDRIDVKAA
LKWLFEHGYVKKSIGKNGQIWTVTSEGRNLYVRIRFKDVQGGVVPA
>VF2148 phosphoglucomutase
MIQFGTGGWRAFIGEEFTKDNVRLVAQALSNIMINEQVQNKGFVIGYDRR
FLSDKAGKWFAEVVAANGIKVSFIDKFVPTPIVMFQTKEMGCIYSACITA
SHNPADYNGVKVFIEGGRDADEIITQKIEQQIAHLTQQDVNALEFEEAVT
AGKIEIINPMNAFVDSIIDFIDIESIKKANLRVLIDPMFGVAKNALQTVL
INGRCDVDVINDGENPAFGGLMPSPSAATLYRLKHLVAHEGYDIGIGTDG
DADRLGIIDEKGNFIHPNEVLILLYYYLLEYKGWKGSVVRNIATTHLLDK
VAADHGEKCFEVPVGFKHISSQMEADDSLIGGESSGGLTIRGHIKGKDGV
FASSLLVEMISVTGKKLSEMLDEIYAKYGYAYTAEGDCTFKPAEKETLYN
KIYVEKQLPEFEYEIEKVSYEDGAKVYFKNGGWVIARFSGTEPLLRIFAE
MEDKPTAEKVLNEMKAFLSL
>VF1931 phosphoheptose isomerase
MSYQDLIRSELTEAAQVLNDFLADDKNIAQIELAAKTIADSFKQGGKVLS
CGNGGSHCDAMHFAEELTGRYRENRPGYPGIAISDPSHLSCVSNDFGYDH
VFSRYTQAVGSKGDVLFGLSTSGNSGNIIKAIEAAKEKGMKTIALTGKDG
GKMAGLADVEIRVPHFGYADRIQEIHIKIIHIVIQLIEKEMEA
>VF1717 transporter, drug/metabolite exporter family
MTIFFPITAVFIWATNAVISKLATEAIEPGAIAFYRWFFAIFILLPFCIK
PVWQQRQQIKAHLGKLTILASLGMVLNQCLAYYAAHTTSATNIAVFLSLM
PLFGLFLAVPLLGNKLKKQALIGAIISFSGLIYMLSEGNPMSLLSNGIKQ
GDGLMFISSLAYALYSVLLNKWKLPLAPWTSVFCQVVIGAALQLPLLLTS
DSYMINHTALPMVLFAAAFASVIAPWCWLQGVQRIGSSQATLFMNLVPVF
TVIVSFIFLGKVPTWYHLIGGSAVLIGLLLAQVKITSMQTALSEKVV
>VFA0468 glucose-6-phosphate 1-dehydrogenase
MTISDNNTIVIFGASGDLTYRKLIPALYHLYASNQLPSTFSILGVSRTQY
DDESYREKMKQSLRELEKTEPEILDAFCHHLHYQALNTSDVDEYSKLVCK
LDQLADKYQLEQQNTLFYLATPPSLYGVIPSCLAAHGLNDESNGWKRLII
EKPFGYDLASALELGKQIHQYFEEHQIYRIDHYLGKETVQNLLVLRFSNV
MFEPLWNRNFIDYVEITGSEFLGVEERGGYYDGSGAMRDMFQNHLLQVLA
MVGMESPSAINADSMRDEIAKVLQSLQPLTEQDLRNNLVLGQYTESEVRG
QFLPSYRDEQGVADDSRTETYVGLKMFINNWRWNGVPFYVRTGKRLPTRV
TEVVVHFKKTPHPAFAENAPENKLVIRIQPDEGIQMRFGLKEPGSGFNVK
DVSMDFHYQSLAETQMLTAYERLLLDALNGDATLFARSDAVNACWKFVQP
ILDFKQDPQALFGYACGTWGPKEADQLLERDNRKWRFPCKNLTDTDYCEL
>VF0666 N-acetylmannosamine-6-phosphate 2-epimerase
MLLLSLEFSFMGSNIDKTLNALSQGFVSSCQPVDDGPMDKPEIVAAMAMA
SVEGGAIGLRIEGIDNLKAVRPHVSVPIIGIIKRDLDDSEVRITPYIEDV
IALKEAGADIIAIDATHRPRPVPVEELVKKIQSLGCLVMADSSTYEEGMF
CHGLGVEIIGTTLSGYTTPVTPKEPDFPFIQQLANQGCFVMAEGRFNSPQ
LAREAIEAGASCVTVGSAITRIEHICGWFKSEVELGKKNMVKDIA
>VF1132 alpha-amylase
MSQATQQHSDPVPIVSNVILHAFDWSYQRITEQAELIAQLGYRSVLVSPA
MKSLNLPSGTKWWQRYQPQDYRLIDNPLGDTFDFKRMVECLTELNIWVYV
DVVFNHMANESDIRADLEYPNQWDREDYAKDPEKYEALTLFGDLSEPLFT
ENDFVEAFGIENWNDKWEVQNGRISGGPHDPGLPTLADNEHVIAQQRAYL
KALKAIGVKGFRIDAAKHMSLEHLEKVWDEEITHDIHIFGEIITDGGATK
EEYETFLSPYLQETKLGAYDFPLFNTLYQALEGEASLTSLIDPYIYGMAL
SPLRAITFATTHDIPNNQVFQDLVMSEENEWLAYAYLFGRDGGIPLIYSE
NEISGFKNTEGNPRWKDEWCSKRMTQLIGFYHEMYGETQTQVEASDEHLV
FARGDRGLVAINKSDHNIEVNVAVKADIVWLEHTSQTYHAPQQGNLRFFI
PAKSYLLFSR
>VF2380 LacY proton/sugar symporter family
MNMKPKSHFKRCIFLLVLFSLFINQYDAIITASFYFLLDIIMLRVSPFAW
ISQYFGGFFFAYGVYLPFWALWFEEQGVSAGDIGVLIGLGFATRCVANLV
ITPRLHRVEHIVPALRLLTLASLIALALFLVNGASFWWLAIVTVLFNLSC
GPAVPLSDAMTNYYAKNNLLDYGRTRLWGSVSFIAGSTVVGYLVSGFGTD
MIVYTAIAGILAALVLVMRNPNPMPVSVSDEDNERPKLLALLTEAPIVKF
IVLVALIQGSHAAYYSFSSIYWKESGYQESTIGYLWSLGVVAEVMVFAFS
KQLFAGWKTSTLFKVAAIGVVIRWGLTAATTELFALVLVQALHGVTFAMA
HLAAIQYIQKFPQNKMVALQALYNAIPLGAFIALMTTLSGWGYEAWGANI
FWLMAAMGVFALLIKLDKVKS
>VFA0989 tagatose-bisphosphate aldolase
MFLVSSREMLHKAQLGGYAVPAFNIHNLETAQVVVETAAEMQTPVILAGT
PGTFSYAGTDYLIGICKEAAKRYHMPIALHLDHHESYSDIQKKVEAGIKS
AMIDGSHLSFDKNIDLVRKVVQFCHRWDCSVEAELGRLGGQEDDLIVDEK
DAMYTDPDAAVEFIKATGIDSLAIAIGTAHGLYKEKPCLDFDRLGIIRGK
TDVPLVLHGASDVPDEDVRRCIELGITKVNVATELKIAFSDAVKSYFIEN
PGANDPRHYIIPGKEAMKKVVQDKIRVCGSEGKL
>VF0183 CDP-glucose 4,6-dehydratase
MNPSFWKGKKVFVTGHSGFKGGWLSLWLQEMGAIVKGYSLPAPTLPSLFE
EAKVGSRMSNEVGDIRDFTHLRQVISEFKPEIVFHMAAQPLVRLSYDDPM
ETYSTNVMGTVYLLEAVKQVGGVKAVVNITSDKCYENREWVWGYREDEAM
GGYDPYSNSKGCAELVASSYRQSFFNKDKYAEHGCALASVRAGNVIGGGD
WADDRLIPDMLKAFSSNQAVEIRSPHAIRPWQHVLEPLSGYITIAEYLYE
YGCDFAEGWNFGPKDEDAKPVEWIVDTLTSVWGDDARWFLSEGEHPHEAH
YLKLDCSKAKMRLNWQPVWDLEYTLTKIVNWQKAWLNKQDMQQYTINEIK
EYMTARAGTK
>VFA0104 hypothetical protein
MFDSASIIIAGSTGLIGHYLLNFSLKNESVNRVYSLSRRSLDETSSKLVQ
MVSDDLSIDKNQLEEQTPDIGFITLGTTIKKAGSKAALKAIDTDLVVSVA
QSMREVGVRHIYVVSCIGASSSAFSHYLKCKGEMEDSIALLGFSSTTFMQ
PGPLSGDRSETRKDEVLLQGVMSIINPLMKGCLLNYKPIEGEVVAECMLD
LALQNDNAVGVHRYRSKAMFEMKS
>VF0816 phosphoglucomutase / phosphomannomutase
MAIHPRAGQKAQQEDLHNIPSLVANYFLLEPNPTNVDQQVQFGTSGHRGT
ADKATFNQHHIWAIAQAVADVRKENGVTGPLFLGKDTHALSEPAFTSAIE
VLVANGVEVIIQENNGYTPTPGISHAILTHNVKCEDKADGIVITPSHNPP
QDGGIKYNPVHGGPAEGELTTAIENRANQLIANELKDVKRVSITEAMSSD
LVKQMDLVQPYIDDLKNVINIEAIQKANLKLGVDPLGGSGIEYWRQIGQA
FDLDLTLVSEAIDPSFQFMSLDKDGVVRMDCSSPYAMAGLLSLKDEYDLA
FGNDPDYDRHGIVTPSGLMNPNHYLAVCIDYLYRHRPEWKPEVAVGKTLV
SSAIIDKVVADLGRDLCEVPVGFKWFVDGLYAGSLGFGGEESAGASFLRF
DGTPWSTDKDGILLCLLAAEITAVTGMNPQEYYNKLAAQHGESSYNRIQA
VANKAQKAVLSKLSPEMVSATMLAGDEITARLTHAPGNGAAIGGLKVTTE
NGWFAARPSGTEEIYKIYCESFKGADHLALIEQEAQEIVSNVFKEAGL
>VFA0810 glycogen phosphorylase
MKTNNIEKFDKAAFKASVKQHLVTTFAADEKTASAKVWYLAMGKALAELT
TFDLVATENDEKIKNARSVNYLSLEFLIGRLTGNNLISMGLYEEITEAMG
ELGYNLTDLLEEERDPALGNGGLGRLAACFMDSLAAQEYPAIGYGLHYEY
GLFRQSFEDGRQKEAPDAWCGVEGYPWEVARPDFAQQVGFYGHVETYTEK
GQEKRRWVPGMSVEGMPWDLPIVGYQSDTVYPLRLWECRAKAPFSLASFN
NGDYFEAQHALIDAGNVTKVLYPNDNHEKGKTLRLMQQYFHCACSIADIL
RRHDAAGHKIEDLSKYETIQLNDTHPTIGIPELMRVLIDVRGLSWDTAWE
ICSNTFAYTNHTLLPEALETWSESLISRLLPRHMEIIYQINYLFLEGVKL
KWPGDVDKLRKLSIIEEGTHRMVRMANLCVVSSYAVNGVAALHSELVKRD
LFPEFNEYFPGKLTNVTNGVTPRRWLKFCNPGLSNLISGKIGNEWPAHLD
QLSDIAVFADDEKFQKEFMAVKKQNKQRLANWVQENMGIELNTDAIFDVQ
IKRLHEYKRQHLDLLNILSLYHRILNEPGFDMHPRVFFFAAKAAPGYHLA
KEIIFAINKVAEKVNNDPRVSDLLKVVFIPDYRVSMAEIIIPAADVSEQI
STAGKEASGTGNMKMALNGALTVGTMDGANVEIREEVGDENIFIFGLEVD
EVEALKASGYSPYKYYEADSLLQASLDLLAGDEFTPGKVGLLSAIRDNLL
YGGDPYLVLADFADYVRAQNDIDAAYRDQKQWAKMAILNTALVGKFSSDR
SIRDYVNNIWKLESVNR
>VF2043 maltose/maltodextrin-binding protein
MIKKISLAVSAALLFSSTAMAADNIVIGVEKSYVPYFTELAEQFNKGKDF
KVEVAATSMFDLLAALPTQKGNIADIFMIPNDRIGELADQHLITPANFTI
NGFTKAATDAATYNGQTYMLPMSTDTTLFLYNKDMVTEVPKTLKEIPPSE
WAAKFTDFYFTGGLFMTNGGYIFQDNNPENIGLNNEGSIKAGLAAQSLYK
SGVGHWTLMQDDTVAYDIMMKYFMEGKLKAIINGPWAIADIEKSGVNVGA
APIPSWDGSHPYKALTGTKGMTINGYSSNKEGANAFIKFMATPENAQKWY
SMTREVSPSLSVTYEEGSLHKAIFDATNIGQPMPSIPEFMKVWGPMKTAL
AQIAQGQDTKAVLDAAVETIEIDIEDM
>VF1997 ATP-NAD kinase
MMDMKRAFNVIAIIGKPRDPNAIKTHLSIYHWLTDQNYTVLLDDRLREAL
PEIPADRFNHLLKLGELADLAIVVGGDGNMLGAARVLSRFDISVIGVNRG
NLGFLTDLDPDNFEEPLQAVLNGDFVKEERFLLEAEVHRHGQVKSHNSAF
NEVVLHPGQVAHMIEFEVYIDDTFAFSQRSDGLIISTPTGSTAYSLSGGG
PILSPNLNAISIVPMFPHTLSSRPLVVEGKRHIKLCISPENRTTLEVSCD
GQVSLPVSPGDEVHIFQSPSRLKLIHPKDYSYYHILRNKLGWSSKLF
>VF1314 hypothetical protein
MSEQPKEKTFILGGSIEKAVSGQFELSPVSVLQEAWKNTVKHFFVFSPAI
LLLTFSYMAVFFLALQIQLGDPAVLFKAFLGETELTTKISYAAFVAGLSA
QVIVSPLTAGASLMGMSHAAGLKCRTSYIFKGIASAGMVALVTILSEVLQ
GMVNIYLPMVALYLSMAFGMSILLVCEKKVSPLQALLLSFRATNKKLASM
LLIHIVIMLALVFGIALYGVGLIVVMPFIFNVKGIIYRNMFGITLKVMVK
DKSGDDEDKPDQSVQNDIFNA
>VF1896 phosphoenolpyruvate-protein phosphotransferase
MVVHLIHAIMARSLELPAIVGTNDITKQVKNGDMLILDAVNNKIVINPSE
AELTESKKIRDDLVAEKEELAKLKDLPAITLDGHQVEVCGNIGTVKDCDG
IIRNGGEGVGLYRTEFLFMDRDALPTEEEQYVAYKEVAEAMHGEPVIIRT
MDIGGDKDLPYMDLPEEMNPFLGWRAVRISLDRREILRDQLRGILRASAH
GKLRIMFPMIISVEEIRELKKAIEEYKAELRAEGHAFDENIEIGVMVETP
AAAAIAHHLAKEVSFFSIGTNDLTQYTLAVDRGNEMISHLYNPLSPAVLL
VIKQVIDASHKEGKWTGMCGELAGDERASLLLLGMGLDEFSMSGISIPRV
KKIVRNATFADVKKMADEALQMPTAAEIEAHVEKFIAENTK
>VF2332 transporter, drug/metabolite exporter family
MMGYEWLALAAACLWALSSMISVTPARHLGAFAYSRWRMGCVTIMLSSLA
WFTGGWLSIESSHLYPMILSGLIGIFIGDTALFACFNRMGPRQAGLLFSC
HALFSAILGYWLFNETLQGWELVGAISVFSGVSIAIFFGKKTDNQGTWDE
VRGNIWIAIFLGLLAAFCQALGGVIAKPVMLTNADPIAASAIRMASAFAA
HSLLRLMNVPISRPITPINFRILGIVALNGFLAMTVGMTLILYALQKGNV
GMVALLSSTTPIMILPLLWLYTKKAPNRFAWLGAFLAVMGTGLIVS
>VF0881 bicyclomycin resistance protein
MSSTETALSEPPKLSILLVIILGAISALTPLAIDMYVPAMPSIASDLGVT
AGSVQMTLTAYTAGFAIAQLIHGPLADSYGRRPVLIIGTVLFAICAVIGA
LVGGIESLMYIRVLQGVAGAASAVVVQAIVRDMFNKEDFARMMAFITLVM
TVAPLVAPMVGGHMAVWFGWRSIFWLLAGFAVLIILAILWRIPETLAEEN
RSPFRLMTSLRNYRSLFKNPVSLGLIFSGAFSFAGMFSFLTAGSFVYIDI
YGVSVSNFGYLFGLNVVFLIIMTTINGRIVKKMGSHNMVKLGISIQLFAG
ILMVVGQLLDWGLWGTVVPVVLFVGCISTIGSNTMGLLLSHYPKMAGTAS
SLAGTLRFGTGSLVGACIAMFPSDSAWPMVSSMAACSILSFGCYFVFGRK
A
>VFA1002 PTS system, N-acetylgalactosamine-specific IIC component
MLFEASLVAVWAFFCGIDKYDVALNIHRPLITGPVVGLIMGDMQIGLIAG
ATLELAWLGLVPNAGAQPPDVTMGTIAAVAFAVMTGQSPEVAMGVGMPIA
VLMQMLVIGFFAMTSFTMGKADKYAEEANTNGIDFLLLSTITMRSMLYAV
IAFLTVYFGEHGAAWIDANAPKTLLEGLGIGAKMVPAIGFAMLLKIMWSK
EVAGVFFIGFVMTTYLQLPIMAVAILGASAAALYYFFSGNGNKNSNQEFE
DFEDGI
>VF1134 HIT family hydrolase
MAEETIFSKIIRKEIPADVVYQDDLVTAFRDINPRAPSHVLIIPNKLIPT
TNDVEPEDELVMGRLFTVARKIAQDEGIAEDGYRLIVNCNPHGGQEVYHI
HMHLVGGRPLGPMLLS
>VF0911 inosine-guanosine kinase
MKFPGQRKSKHYFPVHARDPLVSQAQEAKKMSRTHIIGIDQTLVDIEAKV
DDAFIEKYGLSKGHSLVIDNDKAEMLYNELKDNNMISNEFAGGTIGNTLH
NYSVLADDKSTLLGVMSEDIHIGSYSYRYLCNTSSRMDLNYLQPVPGAIG
RCFALISEDGERTFAISEGDMNQLRAESIPEKIFKNASALVLTAYLVRCK
EGDPMPEATMKAIEYAKKYDVPVVLTMGTKFVVQDDPQYWRDFLNDHVTV
VAMNEEEGEALTGATDPLEAANKTLEWVDLVLCTAGPVGLYMAGYTEDSA
KRETSLPLLPGTIAEFNQFEFSRPAVKDSCENPIKVFSHISPYMGGPEKI
KNTNGAGDGALSALLHDMAANHYHRNNVPNSSKHQHSFLTYSSFSQVCKY
SNRVSFEVLAQHSPRLSRGLPEREDSLEEAYWER
>VF0604 hypothetical protein
MKKILLLCAAGMSTSMVVKKMRESAEQKGLDIHIEAHGVETIQDYLSEYD
LFLLGPQIRFKKDELQKLADEVNKKVEVIDMMDYGMMKGEKILNDALALL
D
>VFA0805 glycogen synthase
MRVLLLSLKERELVTKTLSIVFVASEVDGLIKSGGLADVAKALPKSLKEL
GHSVQIVMPAYKTIAGRDDAEIILTTQLEHWPHTAYQVRSLNVDGIPVFA
IESGDYFERAEMYAENNQAYADNGERFAFFSAATLDLLPKLLNKKPDIIH
VNDWHTGLIPYLLKKRYVENEFYHQTRSVLSIHNAVFKGIFHYDEIACLS
EFKSHFVPEASISHTHVSMLKAGVQCADKINAVSPNYAKELLTELGSHGM
ASDFQDRESDLIGILNGCDYSEWNPEKDSYIPKQFKVNRISMVRGKKACK
AALQQELSLPQKDVAMYGMVCRLTNQKGIQYLLPILEQFLKNDLQLVIVG
TGDPVLATRLTEIAQEHSDKFAFVEAYDNKLAHWVEAGSDFFIMPSEFEP
CGLNQIYSMAYGTLPIVREVGGLKDSVNNYDDDIENATGFSFKNPEPMEL
LLVLMRSLLLYSQNLNEVKRVQLHAMKQDFCWNKAALKYIEMYRTAINS
>VFA0067 oxalate/formate antiporter
MSIFRFPPLVWLGIGILIISLGIRQSFGIFMMPISEHFQTGREFFSFAIA
LQNLLFGIFQPFIGMASDKWGSKRIIIIGAIAYALGLALTSITTESSMLY
VSLGALVGLGLSATSYVIILGAVAKVVPAEHAAKAFGLTTAAGSFGMFAM
IPGAQTLLHDFNWQIAMQVFAMLCTLMVAFALFMKTAKPSSQTAAIEDTQ
TLTEALKEAFSHKGYWLIHAGFFVCGFHVMFIATHLPSYLADKHLPASSA
AMALAYVGIFNIFGSYFWGVMGDKFNKRHVMSALYFVRTIVIGAFVTLPV
TEHTAAIFGGAIGFCWLGTVPLTSGLVRQIFGARYLSTLYGLVFFTHQIG
SFLGAWAGGRIYDYYGSYEPIWWSTVVLAFCAALIHLPINDKPVERLRLQ
SV
>VF1756 tetratricopeptide repeat family protein
MLELLFLLLPIAAGYGWYMGNRSASQQRQKETNHLSRQYVAGLNLLLSDQ
SDKAVDHFIELLQVDSDTIDTHLALGNLFRRRGEVDRAIKIHQNLIARPN
LTIDQRNIALQQLAKDYMVSGILDRAEKIFEQLLEEPDHREAALLQLVAI
HQQTREWEQAIQFANSLVRMGRKKLKLDIAHYYCELAMQELADENLNKAK
QNLKKALSSDNQCVRASIMMAKLLMEEENYKSALAHLESVLDQDIDFVSE
ALPLLAECYEKLDREGALLQFLKEAISKGAGASAELMLSNLIAKHEGVAL
AQGYMTKQLLKNPTMKGFYRLMGYHTDEAEDGRAKASLTSLQTLVGEQLK
MKPNYRCSKCGFSAHRLFWQCPSCKGWGVIKPIRGLDGE
>VFA0887 conserved hypothetical protein
MNTRSSQHTLNGLGWWNIYFIIKIGLFLQGIIDFHPIENFALVAFLLIPI
RHKILNVIRQFLAVPFGLWLMHYDSFLPPLDRLWSQMGQLLQFNLSYLIE
LASRFVSLETLLGLFVLVFAYYFLNQIFRISVFVVITLIAISLPSDLFSS
QPNTVANVSQQPESAETAQISDHQVDETGPVNDAVLNNAKELFFRNEAQR
RVSFPTTSPSTDFDLLFLSICSVAWDDIEIAGLESHPLFKEFDVMFDNFS
AATSYSGPAVIRLLRASCGQESHPELFKAPASKQCFLFDNLAKLGFQENL
LLNHDGKFDDFLGLLKEDGDLKAPLMSQAGLTQYQSAFDGSPIYRDKDVL
NRWLDKREKSQDGPTVALYNTISLHDGNRIIKASGKVGLVSYKLRLKNLL
DDLYDFFQELKASNRNIVVMLVPEHGAGMRGDKMQIAGMREIPSATIVHT
PVGMKIFGQGMTRLGSTAHISAPSSYLAVSTLVSRIIEEDIYATKTFNTA
ELVKDLPTTKMVAQNSGTTVMEYNKKPYVSLDGTTWSEYPTK
>VFA0742 hypothetical protein
MKALRIWFGCVVGFAMCTVFGWSNGMFGTLFPLFILSNLNRWNAQMFIQL
LISIFWVGIQVSLIVGFLQPYPLLMTVAVGIMLLFKCHAMHYKASYLFGY
TGLLVGSILLNFGSYPTFDLENFIIGVWVAAIMMVPICAMAFYLFPDPIE
AHTPILKVEGQSKDPRDMLEQTALGWMVAMIVFLIFEIANLNDSLSAQAS
MLIMLSPMTLVGSLMMARIRIVGTLAGCMAAMAIQLVLYDLYDNPILYIL
SFAIASGYFCKWLASENPAIKGIGFSAMAALTIPITGAIPGQKDAFFSIL
YRVSSIVVAVIVTSILIWICYRLIKLFPIFFRGVEREEKVH
>VFA0987 4-hydroxy-2-oxoglutarate aldolase
MKNNLWIETLRALRVMPVIQIENAEDAVPLAKALVENGLPAAEITFRTEA
AEESIRRIRQAYPDIVLCAGTVLTKEQAQLATEAGADFVVSPGFNPNTVQ
YCLDNDIKIIPGVNNPSLVEQALEMGLSALKFFPAEASGGLNMLKSLTGP
YGNIQLMPTGGVNPNNLLSYLAIPQVIACGGTWIAPTEAIRNHDWDIIAK
NVRETCSLVVGNDDGK
>VF1894 phosphocarrier protein HPr
MYSQDVVITAENGLHTRPAAQFVKEAKGFDAKITVTSNGKSASATSLFKL
QTLGLTKGTNVTISAEGAQEKEAVDHLVKLMDELH
>VF2559 dihydroxy-acid dehydratase
MPTYRSATTTHGRNMAGARALWRATGVKEDDFGKPIIAVVNSFTQFVPGH
VHLKDMGQLVAGEIEKAGGIAKEFNTIAVDDGIAMGHGGMLYSLPSRELI
ADSVEYMVNAHCADAMVCISNCDKITPGMMMAAMRLNIPVIFVSGGPMEA
GKTKLSDQIIKLDLVDAMIQGADPTVSDAQSEQIERSACPTCGSCSGMFT
ANSMNCLTEALGLSQPGNGSMLATHADREQLFINAGKRIVELTKRYYEQD
DESALPRNIADRAAFENAMALDIAMGGSSNTVLHLLASAQEGEIDFDMGD
IDEMSRRVPHLCKVAPSTPKYHMEDVHRAGGVMAILGELDRAGLLNNQTK
TVLGLTMQEQLAQYDIMQTEDEEILKFFRAGPAGIRTTKAFSQDCRWDRL
DDDRKEGCIRTKENAFSQEGGLAVLSGNIAVDGCIVKTAGVDEENLKFQG
PAIVFESQDSAVEGILGGKVKAGEVVVIRYEGPKGGPGMQEMLYPTTYLK
SMGLGKACALLTDGRFSGGTSGLSIGHASPEAASGGTIGLVNDGDIITID
IPSRSITLDVPESELQARRAKQDELGWKPVNRQREVSFALKAYASMATSA
DKGAVRDKSKLEG
>VF0410 hypothetical protein
MTINSRIILNNEQALWQLSPLTDTSLLIKDIPIQQGISSAFDELSLLQVE
AQEWHLMRYFDVDDTLLNYPAIELVMSGVSRYAEVRINGVAVFDCTEKMT
RYRKDIKEYLQVGGNRFEVLFLQEDEDDWLIDDENETKLCDINQAYHRRF
GAVQDIDIKEDIGVFGVCFLQPISHLALNHISIEQIWHHGCELKVNVFFQ
TYKANLISASIKFDGMTLTIPVDVRSDQVSALFQVEAPKYWSDEKNNLDD
LYRVEITLDGQLHELEFGLCETENVIHFPL
>VFA0686 transketolase
MNRKHLANAIRALSMDGVQQANSGHPGAPMGMADIAEVLWRSHLNHNPAN
PEWADRDRFILSNGHGSMLIYSLLHLSGYELSIDDLKNFRQLHSKTPGHP
EYGYAPGVETTTGPLGQGITNAVGMAMAEKALAAQFNKEGHDIVDHFTYT
FMGDGCLMEGISHEACSLAGTLGLGKLIAFWDDNGISIDGEVEGWFSDDT
PKRFEAYGWHVIPAVDGHDSDAINAAIEAAKADPRPTLICTKTIIGFGSP
NKQGTHDCHGAPLGADEIKAAKAQLGWEHGAFEIPQEVYAEWDAKETGAA
KEASWNEKFAAYEAAYPELAAEFTRRVNGDLPKEWEEKASAIIADLQANP
ANIASRKASQNALEAFGAMLPEFMGGSADLAPSNLTMWSGSKSLEANDFS
GNYIHYGVREFGMTAIMNGIALHGGFVPYGATFLMFMEYARNAMRMAALM
KVQNIQVYTHDSIGLGEDGPTHQPVEQIASLRLTPNMSTWRPCDQVESAV
AWKLAIERKDGPSALIFSRQNLAQQERDAKQLANIAKGGYILKDCEGQPE
LILIATGSEVELAIEAAAQLTAEGKAVRVVSMPSTDAFDKQDEAYREAVL
PSAVTKRIAIEAGIADFWYKYVGFGGKIIGMTTFGESAPADELFKMFGFT
TENVVNTAKELLA
>VF2156 gluconate permease
MIEVSTLGAISALVVAITLILKKVPPAYGMIIGALIGGIVGGVSLTDTVN
LMIGGAQGIVTAVLRILAAGVLAGVLIESGAATSIAETIVKKVGETRALL
ALAVATMILTAVGVFVDVAVITVAPIALAIAQRADLSKMAILLAMVGGGK
AGNVMSPNPNAIAAADAFNVPLTSVMAAGVIPGLFGLVFAYFIAKKLVNK
GSKVQAHEVVSVDHSRLPSFTTSIVAPLVAISLLALRPIAGINVDPLIAL
PLGGLLGAVAMRRFRDTNHFAVSGLTRMAPVAVMLLGTGTLAGIIANSGL
KSGLIDILTASGLPSYLLAPISGAMMSLATASTTAGTAVAASVFSHTILE
LGVPALAGAAMIHAGATVLDHMPHGSFFHATGGAVHMDIKERLKLIPYES
AVGLMIATVSTLIFGVFGLFV
>VFA0117 transporter, drug/metabolite exporter family
MMITLVLSSFLSRDNIMRGMIYLIIATILAAIGWGASKMVVMTIPGDIFI
GTRFLLASFVLAPFCFKQFRTLTGKQILALSGVGLVLSFALQVWVYAVSI
TTSLAEGAFIMSLAMIIAPIISWILFRNKPNKAFWIALPISILGMILLTL
GNGWKLEASQLGFMLSALLLSMHFVLNKRIIGAITPLLSICVQLFVVGLS
GCLYASLNSHPSFEITQHAVFWFLISTIVATAIRYLAQTLGQFSVNIETA
SLIMILEPVWTLVLSISVLHEVVAPQKLIGGAVIFLSLFVYIKLSRRLK
>VF2147 N,N'-diacetylchitobiose phosphorylase
MKYGFFDNDNREYVITRPDVPAPWTNYLGTEKFCTVISHNAGGYSFYNSP
EYNRVTKFRPNGTFDRPGHYVYLRDDETGDYWSISWQPVAKSLDEANYEV
RHGLSYSKFKCEYNGIEATKTLFVPKGEDAEVWDVVIKNTSDKPRTISTF
SFVEFSFSHIQSDNQNHQMSLYSAGTEYKNGVLEYDLYYNTNDFEGFYYL
ASTFDPDSYDGQRDTFLGLYRDEANPIAVEKGRCSNSAQTCYNHCGSLHK
QFTIQPGEEVRFAYVLGIGKGNGERLREKYQDVANVDAAFQEIKNHWNER
CEKFQVSSPNEGLDTMINTWTLYQAETCVVWSRFASFIEVGGRTGLGYRD
TAQDAISVPHANPAMTRKRIVDLLRGQVKAGYGLHLFDPDWFDPEKADVK
PSKSPTVVPTPSDDDKIHGIEDTCSDDHLWIVPTIIKYVMETGEHSFFDE
VIPYADGGDATVYEHMKAALDFSAEYVGQTGICKGLRADWNDCLNLGGGE
SSMVSFLHFWALQEFLDLAKFRNNDADVTKYTEMAANVREACETHLWDDE
GGWYIRGLTKDGDKIGTAQQTEGRVHLESNTLAVLSGAVSQERGEKAMDA
VDENLFSEYGLHLNSPSFATPNDDIGFVTRVYQGVKENGAIFSHPNPWAW
VAEAKLGRGDRAMKFYDALNPYNQNDIIEKRIAEPYSYVQFIMGKDHQDH
GRANHPWLTGTSGWAYFAVTNFILGVRTGFDGLTIDPCIPTNWPEFTVTR
QWRGATYHIQVKNPNSVSKGVQSITLNGADVVGSVPVQAEGSINEVVVIM
G
>VF1680 transporter, drug/metabolite exporter family
MSQHQPVQGASWMLTAGLAFAIVNSIAQYVSMNFGLPSTMVALVQYAIAL
VVILPYLRTLGLRNSLRTEHFGMHALRVFLSVIGIQLWLWALAYPVPIWQ
GIALLMTSPLFATIGSGLFLKEKVGAARWFATLAGFVGAMIILEPWSDSF
TWATLLPVGAAFFWACYSLMVKKMSSNDSPSTMVVYLLVLITPFNILLAL
PEWQTPSGMNVWLLLFCAGVMTALAQWAIVKAYSVADASFVQPFDHAKLP
LNVLAGWMVFGWVPPGRLWLGAAIIIASVAFITQWERKKK
>VF1448 ribokinase
MNKLVVLGSVNADHVLQVASFPRPGETLHGHSYSVIPGGKGANQAVAAAR
LGADIAFIASVGDDSFGHQMIEAFQFDGINTEAVMIEENTPTGIAMIQVA
ATGENSICISAEANARLTADRIAPHHGLIEAADTLLMQLETPIETIEKAA
QIAKAAGTKVVLNPAPAHQLSDDLLQLVDIITPNETEAELLTGIQVTDMA
SAQQAADALHAKGIETVMITLGSKGVWISQNGSGRQVEGFKVQATDTTGA
GDTFNGAFLTGLQSGRKLDDAIKFAHAAAAISVTRMGAQTSIPSITEVER
FLLEH
>VF0879 multidrug resistance protein B
MSQSVSIPEGEVVDKPLEPEIPRRHWIALFGGLIGAFMAILDIQITNSSL
KDIQGALSATMDESSWISTSYLVAEMIAIPLSGWLSVALGKRRYLTWTTV
VFTVASLLCSFSWNMGSMIVFRAIQGFSGGALIPLAFSLVVHLLPVNKRA
VGMALFGVTATFAPSIGPTLGGWLTEHFSWHYIFYINLPPAIALLCMVNY
GLDDEPLKLESLLKADWLGIITMAIGLGCLEVVLEEGNREEWFSSSFIIT
LSIISVISLTYFIINELQHKKPLVNLRLLKQSQFAMSCIAYLILGMALLG
SIYVLPMYMIQIQGYNALEIGEVLMWMGFPQLLIFPLVPKLTQIIKAKYL
VFFGFSMFGISCFVNTHMSYLFGGDQLIFSMILRAIGSPFIMVPLSLVAM
EGIQKQEVADASTITNVLRNLGGAFSIAFIATLLDNKTREHLAHIKETLT
SVSTDGWYQLNQSAAMFVAKGSDPTTAMQQAKASLTLTMQRDAAIMAYND
VFFMMSCFLAFAAVLMFFVKSNGKPDPMAGGAH
>VFA0130 PTS system, 3-keto-L-gulonate specific IIA component
MDCVMSLLDLIGNDGIVITTEKGLTLDAALDLTCSLLIKNGKVEASYLEA
IKQKHKEIGAYYVLAPKIAMPHARPEDGVNEAALQITVFKNGVDLESEDN
GDVYFSVTLAAMDSDSHIHTIMALSELFQNEDDVDAIIQAETESDIKDIL
KKY
>VFA0061 PTS system, mannitol-specific IIBC component
MNARAKVQAFGGHLTAMVLPNIGAFIAWGFITALFIPTGWMPNEQFGEIV
GPMITYLLPLLIGYTGGQLVGDKRGAVAGAIGTMGVIVGADIPMFVGAMI
MGPVSAWAIVQFDKRVEHKIPSGFEMVVNNFSLGIIGMICCLVAYEIVGP
AVTAANLFVKSGIEALVATGFLPLLAVINEPAKVLFLNNAIDQGIYYPLG
LQAAAETGKSIFFMVASNPGPGLGMLLAYAKFGQGLSKRSAPSAIIIHFF
GGIHELYFPYVLMKPIMIVAMIAGAATGIATFNLLDAGLVAGPSPGSIFS
YLALTPKGSFIAMLAGVASATVVSFLVASAILKMSKKEQSEDEFEQSVID
MKDMKAEGKAQPQASVEKTGMQPIKFIAFACDAGMGSSAMGASTFKRKLV
KAGYDIEVKNFAIEKVPSDADVVVTHESLEERAIKATGLPVITITNFLND
PALNELLNTIETQQA
>VF2044 maltose transport system permease protein MalF
MSQQFVFWLSMAIPGSGHLLLRRMREAVFGFSMLALEILVYIQFILPNFR
LLAVEQPNGKITIGAERFVDDSFLIMVGSTIGALMLLVFLALHYAFARDA
KDVKRQIEESGFAITFTEKVRGLSHEIVPNLITAPKFILLFIFALLPAIV
SIVVAFTNYKRPILPPAFLIEWKGLTNFERLFTSERTAAAFQETLTWTLT
WTFCASALTIILGTLLAVVANNKHIRGKKFFRTVYILPWAVPAFLTILVF
QLFFSKVGGMNTMVIPFFTGNEYDISTAIGFFLNADYAKITIILIQAWLG
FPYVFILVTGVLQTIPDDLYEASGIDGGNAWTNFFDITLPLILISVAPVF
ITQFTFNFNNVTIVYMLGEATVQTVGSIYKPLDTISSLGFRLMMDAKYNE
AAVYTLITSTVVGAVVLYSWLKAGAFKNEEVM
>VF0807 N-acetylglucosamine-6-phosphate deacetylase
MYALTNCKVYTGNDVLTDHSVIINGTEIEAVCPTSELPAGIELKDLDGAI
LSPGFIDLQLNGCGGVMLNDEITAETMQIMHEANLKSGCTSFLPTLITSS
DEDMRAAIEAAREYHSKYQNQSLGLHLEGPYLNVMKKGIHSVDHIRTSDS
DMIQLMCDNADLIAKVTLAPEQNDPEHIERLHKAGIVVSIGHTNATYAEA
RQGFESGITFATHLFNAMTPMVGREPGVVGAIYDTPDVYAGIIADGFHVD
YANIRIAHKIKKEKLVLVTDATAPAGADMEYFIFVGKKVYYKDGKCVDEN
GTLGGSALTMIEAVQNTVEHVGIALDEALRMATLYPAQAMGLDNKLGRIK
KNMVANLAIFDRDFNVKATVVNGQYEQS
>VF2288 ribulose-phosphate 3-epimerase
MKDFLIAPSILSADFARLGEDVEKVLASGADVVHFDVMDNHYVPNLTFGA
PICKALRDYGITAPIDVHLMVKPVDSIVPEFAKAGATMITFHVEASEHID
RTLQLIKEHGCQAGVVLNPATPLSCLEYIMDKVDMILLMSVNPGFGGQSF
IPNTLDKLRAVRKMIDESGRDIRLEIDGGVKVDNIREIAEAGADMFVAGS
AIFNQPNYKEVIDEMRAELAKVKGN
>VF2146 beta-hexosaminidase
MMDYRVDLVVLSDKEKLNRFGLTLHNLSDVDLHHWQLQFTIDRFIAPESN
SQGTLEQVGSFCKLTPDANQVLKANNHYYVEFSIGTAPFRFITDGLDDAA
IFVDDGKNTHFLDVSISPIVLASPYSERTSIPRVAPSELSLIPKPESVQR
FDGQFNLKDKISLETQTHLAQGAAQWLSDELENITSLKYPIKSQGQIQFI
ANPTLDKGAYQLSVSEDIITLTAGSNEGFVHASATLLQLINERTHLIPCA
KIKDQPRFHYRGMMLDCARHFHPLERVKRLINQLAHYKFNTFHWHLTDDE
GWRVEIKAFPELTQIGAWRGPEEVIEPQYTHIAEKHGGYYSQEEIKDVIA
YAEQRGITVIPEIDIPGHCRAAIKSLPHLLIDSDDNSVYRSIQHYTDNVL
SPAIEGTYQFIDTVLEEIADLFPAPYVHIGADEVPKGVWTDSEKCQKLME
EQGYSDPVELQGHLLRHAENKLKQLGKQMLGWEEAQHGNKVSKDTVIYSW
LSEEAALNCAKQGFDVVLQPGQTTYLDMAQDYAPEEPGVDWANVLPLEEA
YNYEPLAELADNDPIRKRILGIQCALWCEIINNQERMDYMIFPRLLAISE
GMWTQKQHRNWTDFLARLNGRLPTLTRQGINFRQP
>VF0665 N-acetylglucosamine-6-phosphate deacetylase
MNSTNAQNNQYMITNVDVFNGQKIEEKQAIIINNDSISSIISMKEADSLT
LDRIDGEGALATAGFIDIQLNGCGGVLLNTDIALSTLETMNKTNVKYGTT
QYLPTLITSTELDLHNTLSMMTNFENAEQEGVLGLHLEGPFISIEKKGAH
QAQYIRELDLNTAQLLAQHRDQIKVITLAPEHIKQDVLDCLTAAGITVSI
GHTNATYDQVNARTGFTMATHLYNAMTPLGSREPGVVGYIFDKKPHAGII
VDGIHASYPSVKIAHEQLKEKLFLVTDAVTPAGTDLTEFDMAGTPAYVTD
GKCHYKDGTIAGAAITMIDGVRNLISHVGLSKEEALRMASLYPAQALKID
NEYGQLKENYKANITLIDSNNDITTTIQMGKLVYQK
>VFA0711 phosphocarrier protein HPr
MELNTIDYRITFFVKDQGLPPQVASQLTRLAKKFKSLVYIDNITQNRSTN
AESSLGLLQVGLCPGDFCQLITVGMDAEWANFVLTDLLSSTFDFVASDKL
CDFSETITNTYPQLTPQCEVDFHYVKAQAVLSKFEILKGLSQLIYPKESD
ELLLALIKREERSSTAMAKQIALPHVISPYVEKPTIAIIRSDYPVDWASK
MGDVNVIIALVLPEKPTKEMIMAATYLTRSLLSEDFSQRLVHTRQPKGLQ
ALILYAMCQLL
>VF2258 pyruvate kinase
MKKTKIVCTIGPKTESVEKLTELANAGMNVMRLNFSHGDFAEHGQRIDNV
RQVMKNTGKQLAILLDTKGPEIRTIKLENGDDVALVAGQDFTFTTDTSVV
GNKDVVAVTYPGFANDLEVGNTILVDDGLIEMEVVATTETEVKCKVLNNG
DLGENKGVNLPGVSVQLPALSEKDKADLKFGCEQGVDFVAASFIRKEEDV
KEIRELLVANGGENIQIISKIENQEGVDNFDSILEASDGIMVARGDLGVE
IPVEEVIFAQKMMIEKCNRARKVVITATQMLDSMIKNPRPTRAEAGDVAN
AIMDGTDAVMLSGESAKGKYPVEAVTIMAQICARTDAALKAELGSRLDSP
RLRITEAVCKGAVDTAEKLNAPVIVVATEAGKSARSIRKYFPTAKIIAVT
TNTKTAAQLCLSKGITPMIVDSIDSTDAFYLRGKELALESGIGAKGDIVV
MVSGALVPSGTTNTASVHVL
>VF2045 maltose transport system permease protein MalG
MDKAINLNHQTKATKFNRHVLTKNLGLFFSYAFLISMVIVIIYPILVTLM
SAFNVSNSLYSTSFFPENFSLTENFVSLFTDIPYLSWYRNTFLVSIITMV
LSTAIVTVSGFVYSRYRYQSRKSALMSLLIIQIIPSGSGLIALYAIASSI
GIYSSENATLYTYIFMILIYTTGGITMNTILMKGYYDSIPRALDESAKID
GATQMQIFTEILLPLVKPMIMVIAIFCFLGPIGDIIMPKFLIASMSAEAK
TLAVGLMGLINNIKESSYNVFAAGAVLAAIPPVVVFYKFQDYIVGGLTSG
GVKG
>VF0169 hypothetical protein
MSKFTVFGGRGFIGSEFVKELRTQGHDVFVPEREDLSIYEDDLGTVIYSA
GYGDCQRDQFNVLTANVILLSSLLQKAKFDKLVYISSTRVYMNQNESSEY
SDVTICSKDNRRLFNLTKLTAEELCLKSERECLIIRPSNVYGLALNSNLF
LPSIIRNAIKNKHIDMYVDKNYEKDYVSVYDVVSSTLKLIKFPQEVNKII
NISSGENISANDIAQVLINKTGCSIKWKQTLNNTECFSPIDISYLKSLID
YKPRTLINDINNMVDSFIESI
>VF1446 ribose transport system permease protein RbsC
MSTKSMTSTETQQKKGGIFSKEWLIEQKSLIALLLLIVVVSFLNDNFFTV
DNILNILRQTSVNAIIAVGMTLVILTAGIDLSVGSVLALCGAFAATMIGL
EIPVMIAVPTALLAGAALGAISGIIIAKGKVQAFIATLVTMTLLRGVTMV
YTEGRPISTGFTDVADSFAWFGTGYALGIPVPIWLMVIVFASVWYLLNHT
RFGRYVYALGGNESATRLSGINVDRVKIGVYAICGLLAALAGLIVTSRLS
SAQPTAGMGYELDAIAAVVLGGTSLAGGKGRIMGTLIGALIIGFLNNALN
LLDVSSYYQMIAKAVVILLAVLVDNKNK
>VFA0042 hexose phosphate transport protein
MLKFLDQVRKPTLDLPVEVRRKMWFKPFLQSYLVVFIGYLTMYLIRKNFN
VAQNDMISTYGLSMTDLGLIGLGFSITYGIGKTVVSYYADGKNTKQFLPF
MLILSGLAMLGFSFSMGGGSASLFMMVAFYALSGFFQSTGGPSSYSTITK
WTPRNKRGSYLGLWNMSHNVGGAGAAGVALFGANYLFDGNVIGMFVFPSI
IAIIVGFIGMRFGSDSPEAYGLGKVEELFDEEISEEDTAAEENQMTKKEI
FVEYVLKNKVIWLLCFANIFLYIVRIGIDQWSTVYAYQELGLSKETAISG
FTLFEVGALVGTLMWGYLSDLANGRRALVACVSLGLIIVSLEFYQHATSE
FMYLASLFVLGFLVFGPQLLIGVAAVGFVPKKAISVADGVKGTFAYLIGD
SFAKLGLGMIADGTPIFGLTGWKGTFAALDTSAAICIFLLVFVAIAEEKK
IRHAKKMHLAAKQA
>VFA0039 regulatory protein UhpC
MFGFLRSTTSNDNTLSDTQVNESYRYWRLHIMIGMYIGYAGFYFTRKTFN
YAAPAMITDLGLDKGDLGLIGTLFYISYGLSKFLSGTISDRSNPRYFMGL
GLIATGLINIAFGFSSSLAAFISLWVLNAWFQGWGWPSCSKLLTTWYSRS
ERGFRWAIWNTAHNIGGALIPILVGYLTLHYSWREGFILPGIIGVAIGLI
VCWRLRDKPTTMGLPSVGKWRNDPLELAQENHGQGLSYREILKTYVFSNK
YIWLLAFSYVLVYIVRTAVNDWGNLYLTEEHNYSLINANAALSLFEIGGF
VGSLVAGWGSDKLFGGNRGPMNILFAIGIFLSVSALWLMPLTNFVFQAAG
LFSVGFFVFGPQMLIGMAAAECSHKDSAGAATGFVGLFAYMGAALSGYPL
AVILETYGWTGFFITISTCAAVIGLLLLPFLQAQSPQKPIETRVRL
>VF0669 hypothetical cytosolic protein
MIYGHIEHQKTNQYLPRVIQQCLAYLNETDLEALPTGKHIIDGENIFANV
MEFETGDASSKQAEVHKEYVDVQCLIRGEERIQYSLEDEVNPIAKPYDEE
NDFYLVESMNQCNDVIMHPKMFAVFLPEEPHKPGCIVSQSGLIKKIVIKV
HRSLLA
>VF0442 phosphoglycerate kinase
MSVIKMTDLELAGKRVFIRADLNVPVKDGKVTSDARILASLPTIKLCLEA
GAKVMVTSHLGRPTEGEYNEEFSLAPVVNYLNDALDCDVKLAKDYLDGLE
LNAGELVVLENVRFNKGEKKNEEELSKKYAALCDIFVMDAFGTAHRAQAS
THGVGMNAPVACAGPLLAAELEALGKAMSNPERPLVAIVGGSKVSTKLTV
LESLSKIADQLVVGGGIANTFIAAEGHNVGKSLYEADLVETAQKLMKECA
IPVATDVACAKAFDENAEAEIKHVSEVQDDDMIFDLGPDSTAALAEIIGN
AKTILWNGPVGVFEFKNFEAGTAGISKAIAESAGFSVAGGGDTLAAIDKF
GIKADVSYISTGGGAFLEFVEGKVLPAVAMLEERAKA
>VF2105 ribose 5-phosphate isomerase
MTQDEMKKAAGWAALEYVEAGSIVGVGTGSTVNHFIDALATMKNEIKGAV
SSSVASTEKLKELGIEVFDCNDVAGLDVYVDGADEINGKNEMIKGGGAAL
TREKIVAAISDKFICIVDDTKQVDVLGQFPLPVEVIPMARSYVARELVKL
GGDPAYREGVITDNGNVILDVHGMKITDAKDLEDKINALPGVVTVGLFAH
RGADVLLVGAPEGVKKFD
>VFA0128 PTS system, IIB component
MKKILVVCGNGLGTSLMMEMAVKEVAKKIGLEAEIDHEDLSSAASSNADI
WVAATDVATQLEEAGKQNIVSLANIFDKASIEAQLKTFI
>VF0017 alpha-amylase
MKLSVCATLISLSLLVGCQSTPSTDNSSLSENSSNPSSDIAKSTNHDAAD
SVDIICPQLGIQPVTVAVSDLWADGEVVTDAYTGRIAQVKNGSVTLTPSR
HSGGLLLLESKKEEVPFQWKNATFYHIATDRFFNGNSWNDHSYGRQKTAQ
GFQGGDIAGLTQKLDYLAELGVDVLWLSTPLEQVHGWLPGKNGNYPEYPY
AGGATLDWTQLDTNMGTEQEMRIFVDSAHQLGMRVVWSVDTVPSEPSLAD
LQQFNIQPQDASELPSYWNEWQPKDGQNLTNYLDAFKDENGQIPQWWSPA
WSDPSSDGNISTPEFFANKPVTNVAQVSRAKNEVLTQWITTWVAKFGIDG
VVLSDSTPQLTQKIEASASKAFELWKTHNQYKALESSSFLVVDLNEKESF
KPQIVSMQKNKEQCFSQFTYRLSTTEKSHDLYAINWFEERGLDELSEANY
SEYRDTASALLLSQGNLAIWYGDETAKSGEAYSEMNWDQMTGLRLSLMSH
WKKLLAFRANHSALSDGEYQVIENNSYYAFIRKNKSDNVMVVYTGE
>VF2048 amylo-1,6-glucosidase
MKISLSKANFRDMNRLEESNYLLTNGLGGYSSLTLAGSCSRNDHALFMGS
LVAPNSRFCFVRHLDDRLTLANGTSHPLSSQAKVNPYDTVDSSLLFENFS
QTYLPQYTYRIDGIEITKTIVMAQGVNRLGVEYRVFNPLKHPFTLDITPK
YHFCAKGEALSKEQAFIHQEGKVSSNGQTLHYRHNGSNTALSAPSYESGL
YFSYDARDGRSASDAQVALHTITFDGTESNESFFVIFEAEEERAHYLAPS
SIETMINDEVQRQQACITQSGLKSTFAQQLVRASDQFVVMRDSTESKSII
AGYPFFADWGRDTMIALWGCNLSTNQFEDAKQIFRTFIRYEHKGILPNLF
PEAGVEPMYNTIDAALLFVVSLYEYYQASNDLDFIRDEAYDCMVNIYQHY
RNGTDFDIKMLDNGLISGGSGLDQLTWMDVRYGDILPTPRQGCAVEINAL
WYNALSILHFFNQKLGKSMPELPALTEQVKETFNHAFYNDKGYLNDWIKG
EEVNQQIRPNQAYAVGLPFPILSEEKARSVILNIYQHLYTPLGLRSLAMQ
DPEFKSVHTGSHYDRDMAYHQGTVWGFMIGQFLMGILRHFPNDASLMHIV
EQFISHNQDALSEGCIGQLAEIYDGYSPNQSRGCFAQAWSVSEVLRVLKH
YEERI
>VF0986 chitodextrinase precursor
MEHSNLRKKHNYKFTISTLTLSCLMAFNAQAAVDCSPLEAWDAGKVYNGG
EEVKQGTNAYKAKYWTQNNDPATAGEWGAWQDLGVCSGEVPNEAPTVDLT
SPSATEQLTTGDLVTLTASAADSDGNIVRVDFSVDGVVISSVTASPYSTT
WTALEGNHTISAQSYDDKGAQSTVSSVAINVTNTPTDNIAPTATLSLSAT
NVELGSVVTLTADAVDSDGTIDKVDFYIDNTLVGTAATAPYTLQYTTTAV
GSLSVYAKATDNLGATANSASTNLTVTSSLPVADNCRPDGLYQTEGVTVP
YCTIYDKEGREKMGADHPRRVIGYFTSWRDGGDEQNSYLVKDIPWEQLTH
INYAFVSIGSDGKVNVGDVTDPNNAATGKEWAGVEIDPALGFKGHFGALA
TAKAKHGVKTLISIGGWAETGGHFGADGNRVADGGFYTMTTNADGSINHA
AIEKFAVSAVEMMRKYKFDGLDIDYEYPTSMAGAGNPDDKEFMEPRRQYL
WASYQVLMKTLREKLDVASAQDDIHYMLTIAAPSSGYLLRGMETFDVTQY
LDYVNIMSYDLHGAWNDHVGHNAALYDTGKDSELAQWNVYGTEAYGGIGY
LNTDWAYHYFRGSMPAGRINIGVPYYTRGWQGVTGGENGLWGRAPLPDQA
KCEPGTGEGEKNNCGYGALGIDNMWHDKNSYGQEMGAGSNPMWHAKNLQE
GIFGSYANIYGLDPANDPADQLVGTYTRHYDSVAVAPWLWNAEKKVFLST
EDKDSINVKADYVIDQEIGGIMFWELAGDYSCYVLDSNGNRTSVDATEAA
CQTGNGEYHMGNTMTKAIYEKFKSATPYGNTVATGAIPTETVDIAVNVGG
FKVGDQNYPINPKVTFTNNTGQDIPGGTEFQFDIPVSAPDNAKDQSGGGL
QVIASGHTRPNNIGGLDGTMHRVAFTLPAWKALPAGGVYELDMVYYLPIS
GPANYTVNINNVDYAFKFEQPDLPLADLSSGGNNGGNGGTPDAGCDATGL
VTYPDLPQKDWAGNPSHANTGDQVVHNNVIYQANWWTAAEPGSDGSWTKV
CNL
>VFA0797 transporter
MPMVQGKNLKYRVWATHIAMWIFLAMIIFPLLMVITISFREGNFATGSII
PESPSLEHWKLALGIAVEHADGSTTQPPFPVLTWLWNSVKIAAISSVLIV
ALSTTSAYAFARLRFKGKETLLKGMMIFQMFPAVLALVALYALFDKLGQY
IPFLGLNTHGGLIFAYLGGIALHVWTIKGYFETIDGSLEEAAALDGATPW
QAFRLVLLPLSVPILAVVFILSFIGVITEVPVASLLLSDVNSYTLAVGMQ
QYLYPQNYLWGDFAAAAVLSALPITLVFLLAQKFLVGGLTAGGVKG
>VF1413 phosphatidylserine decarboxylase
MWQAIAKQISEVTQQPFSISERESVNGGEINDCYMISNGSQRYFVKINEK
AELPIFETEIESLTQLDKSDHIFVPSPIHIGTTKEHSFLVLNYLPTKSMD
KDAFYELGVSLANHHLWGDQLEYGFDCDNYLGNVLQVNTWHRRWDCFFAE
QRIGWQLQLLKEKGMVLGDIDTLVKNSKLILHNHQPKPALLHGDLWHGNI
ALSVKGPISYDPASYWGDAECDLAMVELFGGIQDSFFEGYESISSISEGF
ETRQHLYSLYHVLNHCNMFGGEYMFHAQQLIDKLNLNE
>VFA0999 N-acetylglucosamine-6-phosphate deacetylase
MRYALYPQRVFVADGIKEHHYVIVNDGKIEAITACEPTDCEILPLEGKTL
LPGFIDIHIHGRAGADVMDATPEALQTISDALLQTGVVAWVGTTVTAPWD
SIVSSIDTVKTWLDKPQQCGAELLGSFLEGPYFTEVHRGSHPTAYLKSPS
IQELEELYDVAAHSLLRVAIAPEADGAMEAIQWLQSQNIKTSVAHTDSTF
EQVTQAHQLGADCGVHLFNGMRGLHHREPGCTGAVLYHDMLAELIADSVH
VHPVMMQLAYRMKGYQQIALITDCMRAGGLEDGEYQLGAQTITVAKGEAR
TKCGSLAGSTCSLDSALRNMIQLSEVPEWEAVQMATLVPAKYLGIDDRLG
SIAPEMEASFVVVNQDFAVQNTMIKGEWVY
>VFA0707 transporter, drug/metabolite exporter family
MSWILFTLLAAFSQSWRNAFQSRLSKELNVTGVTLSRFLWAGPLAAIYLW
LLYYFEPVNLPSFTAYSYFFIIGASVMQIIATGLMVVLFKQKNFAIGAGL
AKSEAPVSAFLGVLFFGTSLSLFGWLGVAIGAVAVFLLSCPDGFRSISFK
TAIIGLACSTSFALTSLWIREASLTLSLPFPHRAAWVLFLVILLQTIALV
SYLLIRDLNTLKEMFIKPKLVVMTSIASFIGSLGWFSAMSLQTVPLVKTL
GQVEVFFTMLISFFWLKEGIKRKDILALILIAIAAVLVMW
>VFA0346 evolved beta-galactosidase beta-subunit
MIILDNLEQFKVVYRDGRKWNRCVEAIENIGNLRDGIMYSIGDSLVYMIE
DGIAKNTETFVGNRRYFDIHYYLEGRETVEVASKSELESVQAYSDETDRE
HLNGNGQKHQLCEGQVAVFDNTKAYKFHGDNRVRKVVLKVTIEDGYFLNK
>VFA0356 aldose 1-epimerase
MIEQSTLFETMTKEATSDGRLAQLFELKNQHGMRAVFMDIGATWLSCKVP
VKGQLREVLLGQSTMADFLEQQSYMGVTVGRYANRIANGQFKIDGIKHQV
ETNQAGNTLHGGPEGFNKRRWNVVEVTENSVEFGLVSSDGDQGFPGDLDV
TVKYQLTNDNEVAISYKAKTNKTTPINLTNHAYFNLLGADSEHLGIDHIL
SVNSQEFVPTTECGIPKGQWKRVKNTNFDFTSPKVISQDFMLDKDQEKVK
GYDHSFVLDKSCSKGESAASLTSPDSLVTMHVFTTKPAIQLYTGNWLAGT
PNRVGGEYQDYSGIALETQFLPDALNHPEWDHPSTILQPNETYQHQTCYQ
FIV
>VFA0709 PTS system, mannose-specific IIAB component
MITDLINEQLICLNLKAQTKDDVFSEMAEHLFQQGRISDKQQFLADIYAR
EELGNTGFEEGVALPHAKSAAVISPAVMIGVSKEGIEYGAEDGLPSRLFF
MIASPANGADHHIEVLAELSSKLIEDGFIEKFLNTTSSKMALELLLQKTD
EAEAVEANKGFLIGVTGCPAGIAHTYLASEALEKGAAELGYQIKVETNGS
IGVKNSPTAEEIEKAEAIIVACDKQVDLNRFAGKKLIQTGVKAPIKDAKG
LITQSLSQPPFVADNSNASSETKDKASQTRSDLYRYLMNGVSHMIPFVVT
GGLLIALALALGGQPTESGMAIPPGSLWNKVLDVGVVAFTLMIPVLAGYI
AYAIADRPALAPGLIGGWIANNGSFYGAEAGTGFIGAIIAGLLVGYFVKF
VANINYNKFIQPLVPIMIAPIAGSLFISGLFIFVIGAPIASLMDSLTALL
TTMSTGNVVLLGIVLGGMAGFDMGGPFNKVAFLFSVGMIASGQTQFMGAM
ACAIPVAPLGMSLATVIGRKFNIFEESETEAGKAAGAMGLVGISEGAIPF
AAQDPLSVIPANMLGSITAAVMAFSFGITNSVAHGGPVVALLGAMNKPVL
AIACMAAGTVVTALVCVSLKKMRQNKNSAPVAA
>VF0481 phosphoglucosamine mutase
MAERKYFGTDGVRGLVGQAPITPDFVMKLGWAAGQVLAKQGTKKVIIGKD
TRISGYMLESALEAGLAAAGLQAKFTGPMPTPAVAYLTQTFRAEAGIVIS
ASHNPYYDNGIKFFSSEGTKLPDDVEMAIEAELDKPMTCVESALLGKASR
LNDAAGRYIEFCKSTFPKELSLAGLKIVIDCANGATYHIAPNVFKELGAE
IITIGCEPNGTNINHEVGATDVRALQAKVVEEKADFGVAFDGDGDRIIMV
DEFGEKVDGDQIAYIIARDALRRGELKGGVVGTLMTNMGMEVALRNLGIP
FVRSDVGDRYVMEKLLENTG
>VF2269 glycosidase
MTAQSDNLRIYQIMVESFVDGDNTIGHGTGYGPSHHNGDLQGIIDSLDYI
QSLGMNAIWMTPVFESAPLDNQDHWADKLDATGYFATDFFKIDPRFGTLE
KAKELVEEAHKRGIYVLFDGVFGHHKKGLIKPSPTGLLPAGEHNPVSYPE
SEAFYKEVATYWIKELKIDGWRLDQAYQVPTQSWTNIRKAVDAASKETFY
TNNKGEQVNPLGYMVAEIWNNENYITETGYGSEQNPALCSAFDFPLRFRV
AETFAVNESGVGHKGGDWLNQGMQMHELYPPHAVPNLMLGNHDVVRFGDL
LQRGDIANPNDKNYWTRHKAALSFQAAYTGPITLYYGDEIGDQVDGFSKK
ENKDTCAIKGLCDDHIARSSAKIDGLTAKLTPEQTDLKNYATTLMQLRIK
HPALSKGKRVNLVANKAVYIDHKQSENDAIVYMVSTQEADQTLSLDAEQI
GSKGNLIDLITGQIFTPMNGIYTIPLSNFESRFLTIEEPNSTGPIIEQKE
IALYGSGFMAQCDNPTITDTNAPLQDTLYLVGDFSDSPWSHKETRAYQYK
GNNIYQVVINEKRGPYKMQYATKGWSAQYTAEGLSPKLGQSNKLITSGYG
QDTAIYLPEDGNYVWSLEFNSQGEPKSMMVSKCK
>VFA0798 maltose transport system permease protein MalF
MTTAVASQTNYKSVLKWGILSAVAALNGYVCVLMYSRGETAFAMLTLVLT
ALAVYVFGSKKNYAHRYTYPGIAGMILFIIFPLVYTVGLAFTNYSATNQV
TLERAQAVHLTKTYQSGKSYSFQLMNQGNGYALTIKDSGQLFATETFNLA
EAVERKLELAPVDSVKGKKATIKQIIAKRPNLNLITLSLPSGEEIQMSGL
RKFAAVGPLFVMQEDGETLYNNKTETYFKANHDTGFYQEVDDNDVFVGDP
ISPGFIVNVGGANFERIWKDDGIKEPFISIFIWTVIFATCTVVFTLAIGL
VLAAVVQWEELKGRAVYRLLLILPYAVPAFISILIFRGLFNQSFGEINML
LDSMFGIQPNWFSDPFTAKVMVLIVNTWLGFPYMMILCMGLLKSIPEDLY
EASAIDGAGPLQNFLKITVPMMVKPLTPLLIAAFAFNFNNFVMIALLTKG
GPNMIGTTEPAGYTDLLVSYTYRIAFEGSGGQDFGLASAIATLIFLLVGG
LALLNLRFTKLSNN
>VF0482 hypothetical protein
MLLLQRFKLLRLIVGSKMSLKELCDGMTMFPQILVNVRFAGENDPLESDA
VKAAQADVEAKLGDNGRVLLRKSGTEPLIRVMVEGEDAELVTQYAQQIAD
AVKESC
>VFA1010 beta-hexosaminidase
MELYIMFKKTLLSTLILAGLAGCSSTSSEQSAVNQLAENLDINYTVITNQ
GADDGLACKELQAEWASCNKVNMTLTNTGEAIDSKDWTIYFHSIRLILDV
ENDQFKITRVTGDLHKLEPTEKFDGFAAGEEVVIPLIAEYWQLFETDFMP
GAFVTAPGAEARNIISLDTEDTGEYVDEIIGVQLKRTLADNNVVATANTR
FEKNADVVEENVAGHIIPTPLKTTLTNKTVDLAKGISITANGIDADQLAA
LNQRAELLGLETAGEYPVSVSVDKKQFKDGVSGAYKLDVTEGKATVVAFD
QAGAFYGVQSLLALVSLDNSEIPTLNVEDAPRFEYRGVMVDVARNFHSKE
AILATVDQMAAYKLNKLHLHLTDDEGWRLEIPGLPELTDIGGNRCFDETE
TSCLLPQLGSGADSDNFGSGYFTTEDYLEILTYAKNRNIEVIPEIDMPAH
SRAAVMSMEARYARLAAEGKMEEANQYRLMDPKDESNVTTVQFYNKQSFI
NPCLDSSATFVDKVITEVAAMHKAAGVPLSTWHFGGDEAKNIKLHAGFQD
INDEEKIAWKGDLDLSKQDFPFAKSPQCQSLIASGEVADFEHLPSHFAEQ
VSKIVAKQGIPHFQAWQDGLKHSEDAGAFATESVRANFWDTLYWGGGASA
YEWAEKGYDVVISNPDYVYMDFPYEVDAKERGYYWATRATDTRKMFGFAP
ENLPQNAETSVDRDGNGFESAGTVTPKKPFYGLSAQLWSETVRTDEQYEY
MVFPRVIAAAERAWHEASWENEYKAGVKYSLQTNLVDKKAQLADWTKFAN
TMGQRELAKLERAGIDYRLPIPGAEIANGELSMNISFPGVTLQYSVDGGK
TWAEYDNANKPKVTGDVQIRSASFTGERVSRVTSVK
>VF1621 methylglyoxal synthase
MNKTTRVMPAHKHIALVAHDNYKPELLRWVKENKDALQGHFLYATGTTGR
ILSKETGLAIKSLLSGPMGGDQQLGALISEGKIDMMIFFWDPLNAVPHDP
DVKALLRIATVWNVPVAMNRASAKFMISAPQMEEEVSIEIPDYDAYLAER
V
>VFA0882 endo-1,4-beta-glucanase
MKMQLTVLSLLIGTLTCSSSAIAQDENYTTPIVSSAALTKENQCEWGQWE
SFKQHYIENGRVVDNSDPRLITTSEGQSYALFFALIANDKKTFDELLGWT
ELHLAGGDLTAQLPAWLWGRQPDGSQGILDSNSAADSDLWIAYSLLEAGR
LWDNHYYQSLGHLLASRILRDETIKVSGLGTVLLPGKVGFVLGKNHVRLN
PSYVPLQLLTRMNTVFPSYQWEEIYQSSAKLLKETMPKGYSPDWVEWDKT
QFKKDSKTQSVGSYNAIRVYLWAGMLPDSDPNKALLLDKMKPLVRVIERN
KGMPETINVLTGKGKNQGGVGMNAAILPLLSSLDSNTNAVEYEKKIQAEL
SKIESDYYYNSVLTLFGLGWYQDLYSFNDDGSVTPKWVNVCQ
>VF0140 UDP-N-acetylglucosamine 4,6-dehydratase
MNSILSLIGRDTELFHQDINANEKELQSVVSQSRFLVLGGAGSIGQAVTK
EIFKRNPQKLHVVDISENNMVELVRDIRSSFGYINGDFQTFALDIGSIEY
DAFIKADGQYDYVLNLSALKHVRSEKDPFTLMRMIDVNVFNTDKTIQQSI
DAGAKKYFCVSTDKAANPVNMMGASKRIMEMFLMRKSEEIAISTARFANV
AFSDGSLLHGFNQRIQKNQPIVAPNDIKRYFVTPQESGELCLMSCIFGEN
RDIFFPKLSEALHLISFADIAVKYLKQLGYEPHLCESEDEARELAKTLPA
QGKWPCLFTSSDTTGEKDFEEFFTDKETLDMARFDNLGIIKNDSLYQQEL
LELFEQKIGQMKTDRQWTKEEIVQLFFIMIPDFGHKETGKYLDSKM
>VFA0301 alpha-galactosidase
MMNPLFFLCGQESIPVQTDLIYEFQNDQISMHFSGIHNLPINDHYLILQF
PTQLEHDAKILGDGFQMLAQTGGKVDSPQEIGRCPDNSPSYRIYSEHAKK
RFYNYLVIEQSDGFTLFGFTSCYRFAGYFEIHEYQGSMNVMAFLDGEFTH
PQDWASNRMESLTVIKAESLAELYELYAAKVQQQHPIRPGVKQDAPIGWC
SWYAYYADVTEKNVLDNVEVMCQKDSEFEWVLLDDGYQAFMGDWLTPSDK
FPNGIKALLQDIKAKGKKPAIWIAPFIAQPESDIFKNHPDWFVHHENGEL
LKAEDITYGGWRCTPWYILDTSKQEVQIHLTEVIHTMREEWGVELFKLDA
NYWGTLKGKRTQSGITGIEAYRLGMQAITNGAGDALILGCNAPMWPSLGL
VDAMRVSDDVERNPQRFEQIAKETFYRSWQHRKLWQIDPDCVTLISLSNQ
GTERKYYEFHRNVILASGGLALSGDPLPDLNKFAKKTWKNILSRLRLTQE
AAQFTSLSNRHCTLTLNHQHELHCLFNYDDEAMEHTLVADQPSIWRDFWT
GEQLNEEPTQMLILTLDSGLNSKAILVSN
>VFA0942 PTS system, fructose-specific IIA/FPr component
MLTLTKNDITLQQSAADKTTAIKAIAKQLATKGLVAENYVDGMLNREQQN
STFLGNGIAIPHGTVDTRELVNQTGVAIHHFPQGVNWGDDNVVYVAIGIA
AKSDEHLGILKQLTKVLSADGVEEKLKQAQTEADIIALLNGEVQFEADFD
ASLIQLLFPASDMIQMSAVAGGLLKNSGNAESAFVAELVTKEPTHLGKGL
WLVSTDKGVKRSGMSIVTTANGCEFNELPVKGLIAIASCNASHQAFLTTI
TKAITEQQQESILSATSEQLLAMFSTSTEETTVNADADNTAIFKIKNAHG
LHARPGAMLVAEAKKYESKITVLNVNGDGNAVNAKSLMKVIALGVKHGHE
LQFTADGADAKEALAGIGAAIASGLGEG
>VFA0713 PTS system, fructose-like enzyme IIC component
MDITSLINANVICLDLTSTSKEDILQEMVQILDDAGKLSNKTQFLSDVWA
REEIGNTGFEDGIAIPHAKSSAVLTPSVAIGISRTGIDYGAEDGEPSDIF
FMLASTDGDDNQHIEALAQISSRLIEDGFTNKLKKADSKEEILDLFTDII
QPNTESTDIENAPSQIEKSELTRKLGRTKEHLLFGTSHMIPFIVAGGVLL
SLSVMISGQGAVPTEGILADIAQMGIAGLTLFTAVLGGYIAYSIADKPGL
APGMIGSWIAVQQYNTGFLGAIIIGFFAGFVVRSLKKIKLPESMASLGSI
FIYPLVGTFLTCAAVMWVIGAPISNAMAALNEWLASMAGSGKIALGAILG
AMAAFDMGGPINKVATLFAQTQVNTQPWLMGGVGIAICTPPLGMALATFL
SPKKFKRDEREAGKAAGIMGMIGITEGAIPFAAADPARVIPAIVAGGIVG
NITGFVFNVLNHAPWGGWIVLPVVDGKIGYIIGTLLGAFTTAAIVILLKK
NAVEDDEHTQQKFTFESVKNEGEADVLAVTACPSGVAHTFLAAKSLEKAA
HKLGIKIKVETQGADGINNRITPLDIKNAKLVIFAHDVAIKEPLRFKGMR
TLDIATKDAMYSAEQLLNDNLTKHHKRFSKA
>VF0385 nitrogen regulatory IIA protein
MQLSTILSLDCTKSAVQCTSKKRALELISEIAAPRIGQSPQELFESLLNR
EKMGSTGIGNGIAIPHGRMFNCDNAVAVLIQCQEPIEFDAIDNRPVDILF
ALLVPDEQCKLHLKTLSSVAEKLNDKQVLRQLRHAENDDELYQIITS
>VFA0892 conserved hypothetical protein
MFIGKWSKDIQGADLHPVIIEIIQYVKEQTEQNTSVGNYPLPHDESVYFI
VDDKTELKENRRSEIHHKYLDVQLLLEGSETFGYSEYPLISIEDDYLEEK
DIAFSNDVKDEQFVTLGKGEFIIFNPKQPHRPLVAVNDTPAAVKKLIIKV
NSALLV
>VF0191 UDP-N-acetylglucosamine 4,6-dehydratase
MFKDKILLITGGTGSFGNAVLDRFLETDIKEIRIFSRDEKKQDDMRKKYN
SPKLKFYIGDVRDYNSILSASRGVDFVFHAAALKQVPSCEFHPMEAVKTN
VLGTENVLEACIANEVSRVVCLSTDKAVYPINAMGISKAMMEKVIVAKSR
NVDPNKTVISTTRYGNVMASRGSVIPLFLRQIMSGDAITITDPNMTRFMM
TLNDAVDLVLHAFIYGINGDIFVQKAPAATIDVLVQALKAITSKPEHEVN
VIGTRHGEKLYEALCSREEMFVAEDQGGYYRIPSDNRDLNYSQYVEEGEQ
DLSTIEDYNSHNTDRLDVDGMIELLHKLDFIADIEAGSLIVPEGV
>VF0186 dTDP-glucose 4,6-dehydratase
MSNILMINKNDLELISDKVESSFGLFKNKNIFITGGTGFFGKWLLEAILY
LNLKRNLNITVTLLSRDPERFKNNYPHLCSSDNISFIKGDVRDFPFPNEY
FNYIIHAATEASSTLNKENPSLMRSTIMDGAKHICNFANTVKCERLLYTS
SGAAYGPQPPNMKAMSEDFIINPNFNVNDAYSSAKLESEDFFKNNLKCQI
IVARCFAFSGPYLPLDGSYAFGNFIRDALDGKNISLNGDGTAVRSYLYAA
DLVIWLMKALVIGQDRTIYNIGSPDPITTLKLAEKICDASGNNSSVNVLN
KSSDSGNIYIPCTLKSQSDLDVEVYTSIDESILKTLKFYR
>VFA1055 transporter, drug/metabolite exporter family
MVNILSLFTLAALWGGSFLFVRIAANPLGPAVLIEVRVAFAALTLLVVSF
FLKKSLRFMSNIKHFLILGLFNSALPFLLFAYSAQVLNVSTLAVLNSTAP
IWGAVIGAIWTRTRLSKDVIFGLILGMIGVSVLVGWEAINIGDEAIIPII
TALIGAFSYGVATNYAKNAPSVEPFNNAHGSMWASVLLVLPLVPFMPVRE
EVTSDIIAAVFALGAVCTGLAYLLYFRLIKELGASSALTVTFIIPVFGIL
WGYLFLGETVGVNAIIGTILVVIGTMFVTGFASKFMSKKCV
>VF2157 glycerate kinase
MKIVIAPDSYKESLTAMEVATAIEAGFKQVLPHAEYIKLPMADGGEGTVQ
SLIDATGGSIIEHTVTAPLGEQITGFYGLFGDGQTAIIEMAAASGLHLVE
PSLRNPLNTTTYGTGELIKAALDKGVKHIIVGIGGSATNDGGIGMAQALG
IKLLDQDGNDLAFGGGSLAQLATIDTLNKDPRLDDIKLEVACDVDNPLCG
PKGASFVFGPQKGATPEMVSTLDNNLSHYADIMKDQLGKDVKDTAGAGAA
GGLGAALLGLFSATLRPGIEIVMDAVNLSDVVSSADLVITGEGRIDSQTI
HGKTPIGVARTAKKFDLPVIGIAGCLSDDCAIVHEYGIDAVFSVVPRSVS
LELALKEAAINVENTARNVATIYSMK
>VF1447 D-ribose-binding protein
MKKLATLISAALLSTSFASTAAAQDTMAMVVSTLNNPFFVTMKEGAEAKA
KDLGYKLIVLDSQNDPSKELSNIEDLTVRGVKAILINPTDSDAVSNAIRM
ANRSGIPVLTLDRGASRGEVVSHIASDNVAGGEMAGKFIMEKVGEKARVI
QLEGIAGTSAARERGEGFMKTVDNGDLTLLGSQPADFDRTKGLNVMENMI
AANPDVQAVFAQNDEMALGALRAVQASGKDVLIVGFDGTEDGIAAVNRGL
LGATIAQQPDLIGALGVETAAKVLKGEKVEKFIPVDLKVITK
>VFA0696 inosine-guanosine kinase
MKFPGQRKSKHYFPVHTRDPLVNQINQTPKLERTHLIGVGQTIVDIEAKV
DDDFLNRHQLSKGHSLVLEESKAEALYKELFERNLISHEYPGDTIGNTLH
NYSVLADSKSILLGVMSEDIKIGSYAYRYLCNTTSRMDLDYLQPVQGPIG
RCYTLISEDGERTFAINEGDMNQLCPTHVPEHIFEKASALVISSYLVRGK
EGDPMMDAVRKAIDCAKSHNVPVVLTLGTKYVIEGKAEWWQTFLKENVTV
VAMNEEEAEALTGEKDPLLAADKALEWVDLVLCTAGPIGLYMAGFTEESI
KRETSKPLLPGNIPEFNRFEYSRPMVKALCKKPIKVSSHIAPYMGGPVEI
KNTNGAGDAALSALLHDMAANYYHKENVPNSSKHDAEYLTYSSFSQICKY
SNRASYEVLTQHSPRLSKSMPEREDCLEEAYWER
>VFA0060 PTS system, mannitol-specific IIA component
MLYDLIDHDLIDVVNHDIDAWEDAVKTTTRYLEQKGYVTANYADAIIQST
YDNGPYYVLCPGIAMPHARPEAGVIKTGLGIHIFPSAIEFGSDLGPANIL
LTLAAKDSDTHIEVIQALSEMLVDEENIAKLTAATSKNEVLDIIKAY
>VFA0438 hypothetical protein
MSVLGYMQKVGKALMVPVATLPAAAILMGVGYWMDPTGWGANSVFAAFLI
KSGGAIIDVMPMLFAIGVAFGLSKDKNGSAALAGFISFTVVTTLLSPAVV
AQLENIPLDQVPAAFGKINNQFVGIIVGIISAEIYNKYSTVELPKALAFF
SGKRLVPILTSIAGMALSFVLLYVWPAIFDALIAFGTQLQSMGAVGAGLF
GFFNRLMLTVGMHHALYPVFWFDVVGINDIPNFLGGAQSIANGTGIPGQT
GMYQAGFFPIMMFGLPGAALAIYHCAEKRNKAAVFSIMLAAAMASFFTGI
TEPLEFSFMFLAPWLYLIHAILTGLSLFIAASMEWMAGFGFSAGLVDFVL
SSQNPLAVKWYMLIPQGLVFFVLYYTIFRFAIKKFNFLTPGRGEDMNKDE
QEENITEVTKAYIEAIGGADNIVEVDNCITRLRLTVKDSALADSAKLKAL
GAAGVVPMGKGGLQVIIGLGKVDKVAAEMKAILNA
>VFA0238 glycerol-3-phosphate regulon repressor
MKQLSRHQEIVNLVQQHGYVSTEDLVEQFKVSPQTIRRDLNELADENKIR
RHHGGATIPLSSVNTAYTTRKVMQLNEKDTIAEALAKHIPDGATLFIDIG
TTPESVAKALVKNHKDLRVVTNNINVAMILMANPDFKVILAGGEVRNRDG
GIVGEATLDFIKQFRLDFGILGISGIDYDGSLLDFDYHEVRVKKAIIENS
RSVYLAVDHTKFGRNAMVNLGSITELHMIITDQEPPEEIVTILKDNEIPY
EVISK
>VF2005 putative phage tail protein
MSNKMFKVKLATPMEVDGKEVSELELRKPTAGDLRGLNLVQVCEMHFDAV
YILLPRISELNERDILNMETENFAPLMTEIASFFVDMKR
>VF0443 fructose-bisphosphate aldolase
MSKIFDFVKPGVISGDDVQKVFEVAKENKFALPAVNVVNTDSINGVLEAA
AKVKAPVVVQFSNGGAGFFAGKGVKLEGQGAQILGAVAGAKYVHAVAEAY
GVPVILHTDHAAKKLLPWIDGLLDAGEAFFAETGKPLFSSHMIDLSEESL
EENIEISGKYLERMAKMGMTLEIELGCTGGEEDGVDNSHMDASELYTSPE
DVAYAYEKLNAISPRFTIAASFGNVHGVYQAGNVVLTPTILRDSQAYCAE
KFGIAPNALNFVFHGGSGSSEAEIQESIGYGVIKMNIDTDTQWATWDGIR
TYEAENRDFLQGQIGNPTGESAPNKKYYDPRVWLRAGQASMVTRLEKAFA
DLNAIDVL
>VFA0957 transporter, MFS superfamily
MNLFEKIGFTSRNQLFGFFSVVMSGQIIYSAFEAFKGTFYNLLLEVLKID
NTQMGILFTLIGSAMFFYIPAGWVNNRFSVKSILITSLSIRFLSMMAIIF
LEPGFSVLVVIAGIWGLVDAAFWPAVVNGVTLMSGDRNKGMAFGLLESVR
RAAEMSMNAVIVGIMALVGGSILVFQGAIVFYTLLILPMIFCVWKFVPDN
HMEIKQGESKNKEALKGLIHVLKMPTVWLAAITSLTVYWIYITLIYTVPY
LQAVFGLSTAQAAIFGIINTGAMGVVAGLVAGSIADFIFKSSIKMMFFAL
GLTAVCLGVTIALPKSEGMLMMNMVLLMCFSFSIFLAKGIILAPVAEAGV
PKDYSGSAMSVGSFAAYASVFWAYALNGWIIDSYPAVQAYQMIFGIGLTV
AVVGMVCSLILISLKKKNSGGDNEKRMVESEA
>VF0440 Transketolase
MSSRKHLANAIRALSMDGVQQANSGHPGAPMGMADIAEVLWRSHLNHNPQ
NPEWADRDRFILSNGHGSMLIYSLLHLSGYDLSIEDLKNFRQLHSKTPGH
PEYGYAPGVETTTGPLGQGITNGVGMAMAEKALAAQFNREGHDIVDHNTY
VFMGDGCLMEGISHEACSLAGTLGLGKLIAFWDDNGISIDGEVEGWFSDD
TPKRFEAYGWHVIPAVDGHDSDAINAAIEAAKADPRPSLICTKTVIGFGS
PNKQGTHDCHGAPLGAEEIAATKAQLGWEYGAFDIPADVYAGWDAKEVGA
EKEAAWNAKFDAYAAAHPELAAEYKRRVNGDLPAEWEEKANTIIADLQAN
PANIASRKASQNALEAFGAMLPEFMGGSADLAPSNLTMWSGSKSLEANDF
SGNYIHYGVREFGMTAIMNGIALHGGFVPYGATFLMFMEYARNAMRMAAL
MKVQNIQVYTHDSIGLGEDGPTHQPVEQIASLRLTPNMSTWRPCDQVESA
VAWKLAIERKDGPSSLIFSRQNLAQQERTQEQVADIAKGAYILKDCEGQP
ELILIATGSEVELAVEAAAQLTAEGKAVRVVSMPSTDAFDKQDEGYREAV
FPSAVTKRIAIEAGIADFWYKYVGFGGKIIGMTTFGESAPADELFKMFGF
TTENVVNTAKELLA
>VF2213 phosphoheptose isomerase
MLENIKESFTESIQIQIAAAEALPDHIMHASQAMVATLLNGNKILCCGNG
GSASNAQQFASCLLNRFETERPSLPAMALTADTSTLTAIANDYNYSEIFS
KQVRALGQPGDILLAISTSGNSQDILKAMEAAVSRDMTIIALTGMDGGVM
AGLLGESDVEIRIPSHRVARIQEVHLLTLHCICDLVDQVLFPQHTE
>VFA0941 1-phosphofructokinase
MSTHLKSKVVTITLNPALDLTGSLDALSVGSVSLISKGSLHAAGKGVNVA
KVLSDLGAEVTVTGFLGRDNEELFCQLFEEMKAKDEFIRVDGATRINVKL
VESDGRVSDINFPGVEVSQQAIAEFEVRLFELAKDHDFFVLAGSLPKGIS
PEQCAEWIEKLHQMGKKVLFDSSRAALAAGLDAHPWLIKPNDEELSEFVG
RELNTPESCQQAAEDLAEKGIENIVVSLGSKGVMWLGQNNQEQAEWMYSQ
PPKMNVVSTVGAGDTLVAGLCWGHMQQDWDRSQILSFATALSALAVSQVG
VGVPDIKNVQELQQQVTLHNPISSNV
>VF1732 PTS system, glucose-specific IIBC component
MFKHLFASLQKVGKALMLPVSVLPVAGILLGVGAANFSFLPEVVSHLMEQ
AGGSVFGQMALLFAVGTALGFTNNDGVAGLAAVVGYGIMVATLKVMATVM
GVDGIETGVLGGILAGGVAGWAFNKFYRIQLPEYLGFFAGKRAVPIVTGF
ASIALGLILSVVWPPIGGAIAAFSDWAAHQNPVAAFGIYGVIERSLIPFG
LHHIWNVPFFYEAGSCVNNAGEHVNGIMTCFLTADDASRAAGNGFGQLAG
GYLFKMFGLPAAAIAIAHSAKPENRAKVMGIMASAALTSFLTGITEPIEF
AFLFVAPVLYAIHAVLAGVAYMLTNALGIVHGHTFSNGFIDFVVQSPRAE
NMLLLVGLGLVYAVVYYVVFRAVIKAMNLKTPGREDEDDSATKVTGSELA
GELVAAFGGKENITNLDACITRLRVSVANVEAVNQDKLKQLGAAGVVVAG
SGVQAIFGTKSDNLKTDMNEWISNN
>VFA0977 possible efflux permease
MAITKMIEFKSKAYYQVSAALAFGSFIVFCNLYLFQPMLPVLAEHFSVSA
TKINWLLAAGTFTLAFMLLPWAIASDFIGRRNVMLLSLFLLPVIGLLSLL
TSHLAILILSRAVMGMALAGFTAVAVAYMAEAFTAKAFSYAIGAYISANS
LGGISGRLFGGIITDYFDWQTAVIFMAALSLIGAMLVAILLPKEGDKALN
KAELSSYVRVVVQHLRNRRLFLAMLIGGVNFALFVNLYSVIGFRLIAEPY
SLPLSVTSMIFLCYLSGTVSSRLVGLWSQRFSSVFGMFVGTLISLIGMVI
TTNDSLITMVIGLNVLSFGAFFTHSLAYGWVSQQAETAKSTATALYLVHY
YVSGSLGGFYLMYCWQHGGWNAVMIGAGFLYMIIFALCWRLNHYAQAKVA
WA
>VF1249 phosphoenolpyruvate phosphomutase
MKNNDIKLSIPNIRRSRLINVIKSHGCIRILETHNPISALIAEKASANDI
DSEENVEYQGFWSSSLTDSVSQGKPDIELLDIKNRISNISDIFEVTSKPL
IIDGDTGGKIEHLSFNIRSLERLGVSAIIIEDKTGLKKNSLLGNEVEQKQ
DTIESFCTKIKKGKESQLTEEFMIIARVESLILDAGMEDALERAFAYSES
GADGIMIHSRHQDGKEIFDFAKQYRSKYPDKILVCVPTSYNEIKFDELKQ
AGFNIVIYANHMLRAAYKAMEYTSEQILKNGRTSEIESHFLSIKRMLDLV
PGTR
>VFA1080 transporter, drug/metabolite exporter family
MNSSYKYTVAGCSAILLWSLIVGLIRNVTEQLGPIGGAAMIYSVGSLFLI
FTVGLPKLKLFSPRYLLIGGGLFVCYEMCLSLALGMANSRNQAVEMSIIN
YLWPSLTVLFAVLASKKPVSKVIYPAILLSFFGVAWTLSGDQGLSITQLM
DNAASNPVSYSLAFTGAFLWAIYCNITKKLANGKNAITWFFIATALSLWC
KYAVSDEASIVMTSEAAIDLLLAGVVMGSGYALWNIGIIGGNMVLLATFS
YFTPIFSTFFSAWILDIELTIQFWQGVIMVTTASLICWWFTREKS
>VF1479 aquaporin
MNKYMAEFIGTFWLVLGGCGSAVLAAAFPELGIGFVGVSLAFGLTVLTMA
FAIGHISGCHLNPAVSVGLWVGGRFDAKDLVPYIVSQVLGGIAAGGILYL
IASGQAGFDLAGGFASNGFGEHSPGGYTMTAALITEVVLTAMFLIVIMGA
TDSRAPAGFAPIAIGLCLTLIHLISIPVTNTSVNPARSTAVAVYVGDWAT
SQLWLFWVAPIVGAVIGALIYKVMAKES
>VFA0712 hypothetical protein
MKIVAVTACPTGIAHTYMAADVLKKAAAKLGVSIKVETQGAMGVENVLTP
VDIVSADLVIIASDIEIEDKNRFLGINSKQFPIETILTDVEGILKKHLF
>VF2503 transcriptional regulator
MADVKVVIGDRLGKGQKVGMGVEAAGGSVTVIPGMAADMKLGDIMKQEEA
DFGISFCGSGGAGAITAQNKYGYKAKYGMRSVEEGVTAINEGYNVLGFGF
MDQEELGKKLVEAFVKKYRS
>VFA0731 glucan 1,6-alpha-glucosidase
MEKRWWHNSVVYQIYPRSFCDSNNDGIGDLQGIISKLDYLQGLGIDVIWL
SPVYQSPMDDNGYDISDYQAIAAEFGTMEDMKRLMQQAEDRGIKVVMDLV
VNHTSDEHAWFVEAKSDKNSQYRDFYIWRDTDENGEAPSDIGSIFGGSAW
QWDEENQQYYFHLFSKRQPDLNWENPEVHQKVFDMMNWWIDQGIGGFRLD
VIDLIGKEVDKKITGDGERLHPLLQKMNQATFGDKDLLTVGETWGATPES
AQLYSDPARHELSMVFQFEHITLLWEDGDKWKPKPLDLALFKQVMTKWQV
ELNNKGWNSLFWNNHDLPRVVSKYGCDGQYRVESAKMLATTLHMMKGTPY
IFQGEEIGMTNVAFDTLEEYKDIETLNFYRVKTESGVSHESMMKGIHANS
RDNARAPMHWDNSDNAGFTQGTPWIKLNPNYPEINVAAALEDKNSIFYHY
QKLIALRKQNPVIVYGDFIPLFETHSAVFAYERKDNDQHLVVLNNFSAEP
QTLALPEHIANRSVECLISNLEPTTQLGSELILAPYQSLVLAL
>VFA0729 transporter, MFS superfamily
MSSLAQWRNPKTFLILISIVVPIAFSTWNALLNNFVIEKAAFTGADIGLL
QSVREIPGFLAFTAVFVLLFIREQKFMILSLVMLAVGVAITGFFPSVYGL
LCTTLLMSVGFHYFETLKQSLSLQWLTKEEAPEMLGKLISIGALASLCTY
GVLWVLLELVQLEFKWIYFIAGSIALIVTIFMWLSFPNFETETQQTKKLV
LRKRYWLYYALTFMSGARRQIFMVFAGFLMVEKFGYSASEITLLFLANYV
FNWLFAKKIGRWIGVVGERKALMFEYIGLIFVFVGYALVQTSEMAAALYI
IDHLFFALALAIKTYFQKIADPADMASTAGVAFTINHIAAVVIPVSFGLI
WLVSPAAVFYVGAGMAFISFLLSLNIPEAPQEGNETRIFKWN
>VFA0770 bicyclomycin resistance protein
MNTNNTDTLSPSRLNKTPLLLAMMIIATGQVGVSIYLPSLPLISQELGIS
SADVQLLVTLFLVGFGGSQLFYGPLSDALGRRPIFILGQGVYLVGTLLCF
TMTNNFTALVLGRLLQGLGAGSASVLGRSVLRDSYSGYHLTKAMSYISIT
ASILPILAPVIGGWVAWHFSWQWVFGFVLIYLICILIIGYFILPETLPYA
PQKFSITQTLRDYTALIKNPQIISSAGLNWVSYLASLVSVSLLPFLLQDG
FGLTAAEYGQTMIIPSAGLMMGSFLLNSLNKRCSINQLMSLALVIMTISG
LWLLFASTSIFSLVFAFTLLAIAQGISFPLSINLLLAPHTHKVGTISALS
GSVQMCLSGLLGGYLVKNWVTDQVNLGIFYLVITISMLLVLLWNKQAQPK
>VF0614 myo-inositol-1(or 4)-monophosphatase
MHPMLNIAVRAARKAGDFVAKSFEQTDKIETTKKGNNEFITNIEADAQYI
LVDMIKKSYPDHSIISEESGLIEGKDTDIQWIIDPLDGTTNFVKGIPHFS
VSIAVRIKGRTEVACVYDPIRNELFTAQRGAGAQRNNQRMRVKELKDLSE
AIISTGFPYRHKQHTESFMKVVGALFIEGSDVRRSGCASLDLCYLASARM
DGFVELGLKPWEMTAADLIAREAGVICTDFVGGTDYLKSGNLVAGSPRVV
KAMLKKVRENGNEAMMK
>VF0043 transporter, drug/metabolite exporter family
MDFLLRTITMNERRALGFGVAAVLLWSTVATAFKITLEHFTPTQMLTIAS
AVSILALAGVAAYQKTLSQLIDTFLANPLYYILLGAINPLAYYLVLFKSY
DLLPASQAQPLNYSWAITLTLMAAVFLGQKIRKQDWIACVLGYLGVIVIA
TKGDVLALEFDSPLGVGLALFSTLLWAGYWILNTKNKADPILGLLLGFLV
ALPVAIGLSIYEGAPWAQIPMSGWAAVSYVGLFEMGVTFVLWLSALRLTQ
NTARISNLIFASPFISLLLLANIIGEEIHPSTLIGLIMIVCGLLIQQFFG
KKEELQTEQ
>VF0304 glucose-6-phosphate isomerase
MLKNINPTETQAWADLTAHFETAQDFNLSDLFAADAQRFDKFSATFGQDI
LVDFSKNLITEETMKKLFALAEQTELSSAITAMFSGEKINKTEGRSVLHT
ALRNRSNTPVMVDGEDVMPAVNAVLEKMKGFTERLISGEWKGYTGKEITD
IVNIGIGGSDLGPYMVSEALAPYKTRLNMHFVSNVDGTHIVETLKPLNPE
TTLFLIASKTFTTQETMTNAHSARDWFLAEAGDQAHVAKHFAALSTNAQS
VSEFGIDTDNMFEFWDWVGGRYSLWSAIGLSIALAVGFDNFIELLEGAHE
VDKHFAETDLENNVPVILALIGLWYNNFHGAESESILPYDQYLHRFAAYF
QQGNMESNGKCVDRNGNPVDYQTGPIIWGEPGTNGQHAFYQLIHQGTKLI
PCDFIAPAISHNQVGDHHQKLMSNFFAQTEALAFGKTEETVKAEFAAAGK
TEAEVAELVPFKVFEGNRPTNSILVKQVTPKTLGNLIAMYEHKIFVQGVI
WNIFSFDQWGVELGKQLANQILPELADDKAVTSHDSSTNGLINAFKAFQA
>VF0912 aldose 1-epimerase-like protein
MNLTQLPIISVLSDNVTVAQLDDVKVIRVIHDKANAAISLHGGHVLSFTP
KGQDDLIWMSKEAIFNPEKAIRGGVPVCWPWFGRIADPAHGFARNNEWTL
IEHRENDNGVIIVLGLEASEATKAIWPFEFEARLTVEIGDELRITLDAKN
TDSKAWNCSGALHTYLNVADIASTTITGMGPTYIDGLQNAKLCTGEDTLS
ISAAVDRVYTQPENTVSVSDSQRTLTVTNSGHNAAVIWNPWIEGAESMAD
MNNDGYKTMVCVESTYHATSLEEAQTVEPGNAFTLTTTIKA
>VFA0960 maltose/maltodextrin-binding protein
MIRKFSIDEMKAELLLASRSKNYMPDVAWVPSDFLGLHKFIGISPIPKVW
INQDQLEPAARQSAMVGDSYMGLPLFLGNHLMLFYDKSKTPTPVTQWEQL
QALSEKEPEKTHIAFSSRDMYFFSAFFSLFHPEIPLDQIHFKDHECMNTL
VFFHELVRLNHLGSQCNSLCSRQLFIDGKASYLIDGDWAVSDLREKFGSN
LGIASLPSYRGIPMKSLSAGKVLMITKTALQNPAKRVMIKQLLTMVQDKA
FLTKLINEHQYISASTEVNQISIQPDQEVMYAVYQQYLQSQPMPTSVRVS
FIWEALARGVSRYSDGMPKEETMLYINQLIDRFSKKVEGS
>VFA0157 permease
MPSFFDKNTHASIQLIIIGLIAALMGIGQNGLLVSLPFLVTHSAFALPTW
SIVIAVGSFLFLPSAPFWGKYSDKKGPKFVVLQALFGMSFSFLLLLTFTF
FSNDHPNYAGFCLIGLIVARVIYGCTVSGMVPASQHWAILLCGENNRLQA
ITSVSIGLSLGRLLGPILSILLLKSGPYSPLIMMICFPLLALFAAFMLPS
PSQINKHNKSSHQVSSFIPNVRLMPYLLTGLFLCLTIALLQYSFSPLIED
ITHWSTNKISDVIGILLTISAAVTLITQVFVIKKKKIQITTMYYLGAICL
LLGYLIFTLHSIWLLGIGMAITACGAALLVPAYTTKATSIDKDNPGSVAG
YISMSHTLGYGIASLFAYTATISPIYPIYLCILFSVGILVIAFMKPQINK
T
>VFA0819 transporter, drug/metabolite exporter family
MAASAIEPSAMSFYRWAFAMLILTPFCLPSVIKSRHVIRPYLSKLAFLAL
LGMVLNQSLGYYAGLTTTASNMSLITSLVPLISIFLSLPLLGKRISALSI
VGAVISLAGLTFMLGHGDMTFFLHQPITEGDGLMVIAALSYGAYCVLLKR
WKMPITNWQLIYMQGMFAVAMLTPLWLTSDSLLPTESSIPLIMYASIAAS
ILAPWMWVKAIDVIGAESSAMFMNLLPVVAVSLAAILLGEKIESYHLMGG
IMVISGVILAQIKTKKAKQEASVLVKA
>VF2049 neopullulanase
MITKAAIYHRSHSSYSYAYDKDTLHLRIRTAKGEVDNATLRIGDPYDWTF
GGGGGNLNAEDASGWTGGTNLPMIKECETELFDYWFCEAQPRFYRARYAF
LLEGKDSEKLLVSEKLITQITDDADPILSQLLNFYCFPYMNPTDVFNAPE
WVKETIWYQIFPERFANGDPSISPKNVLPWGSEDPKTNSFFGGDLQGVID
HLDYLQDLGITGIYFTPITQGETNHKYDTTDYLKVDPAFGSDETVHTLID
EAHKRGMKVMLDAVFNHIGANSIQWQDVIKHGKDSQYIDWFYVEQFPLID
ESKKAYHSKEQLNYRAFAFAQNMPKLNTENPEVIEYLIEVGRYWVKNFDI
DAWRLDVANEVDQRFWRRFRDELKAIKPELYILGEVWHDSMNWLGGDQFD
GVMNYPLADAMLGFFAHDT
>VF0913 glyceraldehyde 3-phosphate dehydrogenase
MTIKVGINGFGRIGRFVFRASVERNDIEVVGINDLIDVEYMAYMLKYDST
HGRFNGTVEVVDGNLVVNGKTVRVTAERNPEDRKWDAINVDVVAEATGLF
LDDATARKHITAGAKKVVLTGPSKDATPMFVMGVNHESYAGQDIVSNASC
TTNCLAPVAKVLNDKFGIESGLMTTVHATTATQKTVDGPSAKDWRGGRGA
SQNIIPSSTGAAKAVGVVLPELNGLLTGMAFRVPTANVSVVDLTVNLKTA
ASYEAICAAMKEASEGELKGVLGYTEDAVVSQDFIGEVQTSVFDAAAGVA
LTDKFVKVVSWYDNEIGYSNKVLDLIAHVSK
>VFA0030 transporter, drug/metabolite exporter family
MFLSALGFALMSACVKYVSNYGIPVFEIVAARALVSLIISYADVKRKGIS
IWGNNKPLLLARGAVGTTALMCVYYAVTTLPLAEATILQYVHPIFTALLG
VLFLKEHIQKSTMICIAFCLAGLFVMVQPSMDSGSTSELPIFSIAVALCG
ALGSSIAYVIVRKLSQTEDSSVIIFYFPLVALPISTVLIWNDFVWPSLFL
TMILILIGIFTQIGQYGLTKAMQTQAAGKASAYSYVQIVFSALLGVWIFN
EIPSIWTYLGGGLIVTGALINVFGKQSVSTLKKSS
>VFA1104 multidrug resistance protein B
MSKNGATIAVMLAVLMVQIDITVANVSLPHIMGSLGTTVDKIPWILTSYS
MAEAIFIPITSFWVARFGERKVMLVAIIGFTIASMLCGTAQTLAELVIYR
IFQGMFGASMLPLAQSTIAQLYPAGQRGRGMAIFSIGILLGPIFGPIIGG
IITDNINWRWIFYINLPVGLISIYLIYKHIHLNNRSKSKFDWWLVSYMAI
FISSLQFILDRGNEKDWLDSRLIQILLAFTIIGGIMWIYRSLKTKGSIAP
LWVLKDRNLLASSIIGGLISMCTSGLGVQLSILLEEVLNYPVLDTGLLMT
PRGLVSAFVLVLVIKFNPQFDPRLKILFGLLCLGLGNYLMTKYSLNIDTF
WIVFPGMIQGLGLGLAFSTLSVVAYLTLPTQHSIAGASIYNLFRILGSAS
GISIVTTLQYRDSQQQWHGLTEGFSPYNPDLQKWLQLNDLSITDPESILR
YENMIYEQSQIVVFTHMYQWIGMSVIFLIPLLLLIKVKK
>VF0609 outer membrane protein S
MKLLPVALAVTATLSSFSTFAETDPLDNIQLDDQQPLVISPQSDIPDGIV
FSGYARYGFHFSDDTQKYVSADGQLIGNAAGRLGNESNGGEFQFAKGFVS
DNGTIWDVVVMLEHWGDEVGLKKFYAGATNVFESQPNAYIWAGRDFHNRP
QTGLNDYFWMMNDSQGAGIKNLEFGNVKFDMAAVAQVVDGGGTGDSGNYA
ITSKLHGINLTDALDLSFYANYGFSSKNTETDKDTQTCTGTGADKQCYVD
DIDSYQLALELNHSVGMLSNKFVARYGNNVDNNIFNKTEDLSTLLMQLEG
KLVMSNQTNIEYLVGYQSLEDKNASQDDRANYSAIVRPTYAWNNIHSTWL
EAGYSLVDFDNQSGQNDAWKVTLSQNISFDMDSGARPMLRFYATVGDSNT
EVDLTRGETSKQDTFAVGAMWEAWW
>VFA1003 PTS system, N-acetylgalactosamine-specific IIB component
MTGPQIVWTRIDERLLHGQIRITWGKHSEANLILVANDEAAEGPNAAFMQ
AGMKASAGGEYAVRFFSIQKTIDVIHKASPKQKIFILCNNPTDVARLVEG
GVPITHCNVGNMHYHDGKRQIAKTVSVDKTDILAFEKMVEKGVTCTVQNT
PDQTPINVLELAKTAA
>VF2050 putative cyclomaltodextrinase
MAFSLLDSHDTPRIINRCNGNKEKAKLAYLFQFTHSGTPCIYYGGEIGLD
GGVDPLNRKCMIWDERQHDMNMKHHIMQLIKLRKAHPALRAHAINWLVVD
DEQQCFIYQKEYQGERIIIAMNNSNAPACMTLPSEWRDQEVTDIYHETAV
KLTQSLTVPAFGFAVYQI
>VFA0710 mannose-6-phosphate isomerase
MNALKPQTFYPMTNVIQDYAWGSHTSIEALFDIKNNTGKPQAELWMGAHP
NGCSAVTVNGDSVLLSDLINQDKEAFLSKTTADAFGELPYLFKVLAAEKA
LSIQVHPNKQQAVDGFEKEEKTGIALTAFNRNYKDNNHKPELVYALTDYK
AMNGFKDYQEIVSLFSAMQLPTIASYVDDLAQEPNSNGLQRFFKAILSLE
NETKERAVAELLDYASNSTDELFVLLQDLAIQYPNDVGLFAPLMLNVITL
KPGEAMFLSACTPHAYIHGTGLEIMANSDNVLRAGLTPKYMDIDELMSCT
EFVSQPLSSLLTQPNTVDGGMSYPIPVNDFKFSVFTATDALTLETNSAEI
LFAIDSDLTLTHENGESVTIAKGHSVFVPAYAKRYSLTSSGNVARAYN
>VF1242 phosphoenolpyruvate synthase
MTDTILPTLNRVASLPSYQSETDSDASLYVSIAALIQEHLFYHPKAVIKA
PEMTSIDAQSFAAIIESAADGKTHFIDTLANVILSNVTEATKEIKIAFSD
ADSAAFAGLLAGQLEEKETNPMMGVRGVTRYASDASADQFALECEVIKKV
IANTSASVQIVVPFVRNLSDAATIIDRLAIQGLPRGLDSLKVHFVCDVPA
AALMADKLLQYFDGMVINVDTLTQFTLGVDKQNEALEHHFEPQNDAVIHL
IGHAIQSANKANKPVLTTIDELAQNLRIQELLEQLNVVDVVVTA
>VF0883 nucleoside-diphosphate-sugar epimerase
MAHRIIIVGASGYIGSQLIPLLLEQGHQVIACARNIQYLTDRVQQHPNLR
CEYLDLENKTTIEPLLFDCDIGYFLVHGMSHGHDFIDYEVSLAQNFADAA
EQSQLKRIIYLSALQPENHQSQHLLARQKTGEILRSTGITTIEIQSGIII
GAGSAALEIMTDFINHLAIILCPKWIHSQANPIAIDNLNDYLIQCLDIEV
SNSLSLEAGGPDTVTYLQLFNLLAKRLNKSIKIIPTRFISPKFAGLWLGI
ITSVPSELGRALLAGIDHDLLADNSKIQQLMPQTLTPLPEALKLANHTSA
NSLQGEIWGFDPSALRRWQPDYGYYPKQAGASFTTNASANSLWKVILQLG
GPEGYFFANGLWRTREWLDPLLGGSFPIRRKPKSDQLQLGDYIDSWKVIR
CENNEFLSLLFGMTAPGLGRLEFSIKELENNTRELDVRAWWHPKGFWGLM
YWFAMFPAHLFIFKGMVKAICKKAEKEEKG
>VFA0809 4-alpha-glucanotransferase
MRAVLYCPWRKAMKDNNNVLHQVAELAGLKNSYVSAWGNEAKVSDETLIR
LLASLGYDTKNDKTLLSSAEKKHKKDVLSTVQVVRDNELLQVEMNLGKSA
RISEFSWKITTEEGEVLEGYLQSQIVSDERENDGTLLFSLPTLPWGYHKL
EVIRKRRKAPYEMTLIVTPKACFKQDAMLKGKKMWGPSVQLYTLRTPHNW
GIGDFGDLKQLVGDIAVRGGDFVGLNPIHSLFPANPEGASPYSPSSRRWL
NILYIDVCSVPEFALCNQAQELVGSAEFQQRLADARQSHWVNYSEVSALK
MSVLPLLFSEFKTRHLDKKSARAKAFLEFVAEGGESLLHQAAFDALHNSL
YSQDNSIWGWPVFPHELQHFDNKAVQKYIADNRDQVDLYMYLQWVAFTQI
NDVQQFAENKGMDVGLYRDLAVGVADSGSETWADHGNLCLDVSIGAPPDI
LGPLGQNWGLPPLNPHTLKETSYEAYVQLLRANMKACGALRIDHVLGLLR
LWWIPKGEDATKGAYMHYPVEDMLSILALESHRYQCSVIGEDLGTVPDEI
VDLLAEAGIHSYKVFFFETSEDGGFYSPAHYQEQSMSALCTHDMPTLRGF
WHCDDLKMGEEIGLYPDPEQLKELFNTRAESKQEILNSVDFHGYLPEGVG
RDASFVPMDRYLSDALQCHLAAGSSTLLSLQLEDWLEMDKPVNIPGTVNE
YPNWRRKLSVTLDDIFNRPQVNELTKRLTDIRAQASQK
>VF0152 ADP-L-glycero-D-manno-heptose-6-epimerase
MIIVTGGAGMIGSNIVKSLNNKGFNDILVVDNLKDGKKFKNLVDLDITDY
MDKEDFITQIMAGDDFGPIEAIFHEGACSATTEWDGKYIMMNNYEYSKEL
LHFCIEREIPFLYASSAATYGETDTFIEERAYEGALNVYGYSKQQFDNYV
RRLWADAEEHNETLSQITGFRYFNVYGPREQHKGSMASVAFHLNNQMNAG
DNPKLFEGSDEFKRDFVYVGDVAAVNLWFLENGVSGIYNCGTGRAEPFRA
VAEAVIKHHGKGEVETIPFPEHLKGAYQEFTQADLTKLRAAGCDVEFKSV
ADGVAEYMAMINK
>VF2373 transcriptional regulator, DeoR family
MSKRNTKQRRHMILSLLTEQGEVSVEHLSDLFDISEVTIRKDLTELEKNG
LLMRKYGGAVLMPSNIIQEDNCEEVSNRKLSIAVAAVELIKDHNRIIIDS
GSTTAALINQLSKRNGLVVMTNSLPVANALQEIENEPTLLMTGGTWDSHS
DSFQGKVAESVLRSYDFDQLFIGADGIDLERGTTTFNELVGLSRVMSEVA
REVILMVESEKIGRKIPNVELPWESIDVLITNNDLSPEQQKKIESHNVKV
IRA
>VF1388 dTDP-glucose 4,6-dehydratase
MTSISVLGCGWLGLPLAKHLVDTGFMVKGSIRSSNKISELEKNHIKPYLL
DIDAVEQSWSQFLTSDVLIIAIPSKNIEGFTSLIPIIEASSIKHVLFVSS
TSVYEDANRVVTEEDATIPSSALSQIERLFMQSTKFTTTVIRFSGLVGYS
RNPGRFFAKSGRSVSNPDVPVNMIHQDDCIGLITQIIKQEKWNEIFNACA
DTHPSKREFYTQATQRIGVETPTFIESNEQTFKIISNHKIKEALGYEFIH
PDVMNITYDS
>VF1056 phosphoglucomutase
MMQKVTEWLMRDPDPKTREELQCLVDSHNTQELEERFHSRLQFGTAGLRG
KVGAGPNRMNRLVIQETATGLGHYLIDQVKDAKQRGVVVGYDGRNDSKQF
AHDTASVLTALGIKVFLTSKVAATPIVAFGIKHFNAAGAVVVTASHNPPE
YNGFKVYWENGAQIIPPHDSGIAQTIDIAATKSIVMMPLDEAEEKGLLVW
LEDDYYQTYRNTMNSNKLLSNHTDPSSITIAYTAMHGVGADMAETLLRDA
GFNHVFSVAEQREPDGNFPTVNFPNPEEAGAMDMVEALAASANADIACAN
DPDADRFALAARKPDGGYKMLTGDQVGTLFGHYLLTHTEASGKLVGNTIV
SSTLLKKIAESMGAEYFQTLTGFKWLTNVAMQKETKEKQFLFAYEEALGY
TIGSQVWDKDGLSALVAFAQLTAELATQGKCVWDQLESIYRQHGIHINAQ
RSIALNPDSPAIGEHLRANPPTHIAGVKIDVVEDLKASLRYLPDGATESI
DLPASDVLIYHLENGARIIVRPSGTEPKLKCYYEVVADISEGEDYFDKQV
QAQAAMDNLIAEHQKSLTF
>VF0383 phosphocarrier protein HPr
MPISSRHLLIKNRLGLHARAAIKLVEMAQSFDAVITLTNEENTQATADGV
MGLLMLDSSQGQYVDVSADGVDAEQALNAICELIEAGFDEDE
>VFA0347 beta-galactosidase
MNNWENFFRLNENRMAPRAYFFSYDSVQAARTFQRELSSHYQLLSGQWTF
NFFTNPLLVPEEFYSQHMSDWGNITVPNMWQMEGHGDLQYTDEGFPFPID
VPFVPSDNPTGAYQRTFTLGETWNNKQIIIKFDGVETYFEVYVNGNYVGF
SKGSRLTAEFDISEFAQQGENLLSVRVMQWADSTYIEDQDMWWTGGIFRD
VYLVGKEQVHVQDITIRTDFDENYQSATLSCKADLENLTNNSVSNYSLGY
ALFDGQTVVSEGTVNSLSFDANHCVDINIDMESPTHWTAENPYLYQLILT
LKDENGKTLEIIPNRVGFRDIKVRDGLFYINNKYVMLHGVNRHDNDHLKG
RAVGMDRVEKDIVLMKQHNINSVRTAHYPNDPRFYELCDVYGLFVMGETD
VETHGFANVGDLSRITNDPAWEHVFVERIERHIHAQKNHASIIMWSLGNE
SGYGCNIKSMYDAAKAIDDTRLVHYEEDRDAEVVDIISTMYSRAQLMNAF
GEHPHNKPRIICEYAHAMGNGPGGLTEYQNVFYKHDSIQGHYVWEWCDHG
ILAKDENGTEFLKYGGDYGDYPNNYNFCMDGLVYSDQTPGPGLKEYKQVI
APVKIRAKDTANGVFTVDNKLWFSNLDDYTITAEIRAEGETLQSTTFKVE
GLTENSSRDIEITLPELDGRETFVNFTVRKNSRTLYSEANHDIAVYQVQL
KENTEQLPVFTNSNAIALDITASRLDYVVKGLNFALTFSKVNGKLTSWVV
NGDELIASAPKLNFFKPMVDNHKQEHEGLWEPAHLQIMQEHFRSIDLDAS
NGKATFTVTSIIAPPVFDFGMRCTYVYEINKEGQLNIQLSGERYGDYPHV
IPVIGLDLGINNDFDQVQYYGRGPEENYQDSQQANMIDVYQTTIADMFEN
YPFPQNNGNRQHVRWASLANRHGNGLFVKPEQEINFSAWFYTNQNIHEAQ
HTIELEKSGYITLNLDHKLMGLGSNSWGSEVLDSYRVYMDKFQYALTLVP
FQQGGCSPKALANHTFISNTAFTSKTTIEGGEK
>VF0264 fructose-1,6-bisphosphatase
MSEIRTLGEFIVAKQHDFPHASGELSSLIGSIKLAAKIVNREINKAGLVD
ITGASGEENIQGEQQQKLDVYANDKFKSALEARDQVCGVASEEEDEAVAF
NKELNKNAKYVVLMDPLDGSSNIDVNVSVGTIFSIYRRISPIGTPATEED
FLQPGHKQVAAGYIIYGSSTMLVYTTGNGVHGFTYDPSLGVFCLSHENMQ
IPKDGNIYSINEGNYIRFPEGIKQYLKFCQESKPEDNRPYTSRYIGSLVA
DFHRNLLKGGIYLYPSTQAYPNGKLRLLYECNPMAMLIEEAGGKATDGEQ
RILDIKPSELHQRVPFFVGSTNMVNKVHAFLDEWRD
>VF0072 glycerol-3-phosphate transporter
MFGVFKPKAHIAQLPTGEINSTYKRLRWQLFLGIFFGYAGYYLVRKNFSL
AMPYLIEQGYSRGDLGVALAAVSIAYGLSKFLMGSVSDRSNPRYFLSAGL
VMSALVMFCFGFMPWATGSITAMFILLFLNGWFQGMGWPACGRTMVHWWS
RKERGEIVSVWNVAHNVGGGLIGPMFLLGLWAFNDDWRTAFYVPAFFALL
VAFFVWLTVRDTPQSCGLPPIEEFKNDYPDDYDSAYETEMTAKEIFFKYV
FSNKLLWSIAIANAFVYLIRYGVLDWAPVYLKEAKEFTVDKSSWAYFLYE
WAGIPGTLLCGWISDKLFKGKRAPAGILFMALVTIAVLVYWFNPAGNPTV
DMIALVAIGFLIYGPVMLIGLYALELAPKKAAGTAAGLTGLFGYLGGAVA
ANALLGYTVDHFGWDGGFMILVASCVISIVCLTYALIGEQKHHKEKIEKE
SHMA
>VF0197 UDP-N-acetylglucosamine 4,6-dehydratase
MQFLQPIWSMPRPLKRLVSIVVDILFIVFAFWAAFATRLDGIEIYMQDVS
YWKLLAVLIPCTLLVFTKSGLYRAILRYLSLHAVLSICISAIISSAFIVF
ISYFNYLYMPRSIPVIYATYLVMLCGGSRLIVRVLVSDLLGKQKKKVLIY
GAGSAGLQLANMLRQGKEFHPIAFIDDDRKKHKTTMQGITIYRPKYLERL
IKKHCISTVLLAVPSASQVQKKVIIESLAKLHVEVLTIPNLDDLVNGKLS
IGQLKEVSIDDLLGRVAVTPQAELMEANIKDKVVMVTGAGGSIGSELCRQ
IILNKPTTLVLFELSEFSLYQIEHELSQIIANQQLSINVVPLLGSVQRLN
RLAATMKAFKVQTVYHAAAYKHVPLVEYNVVEGVRNNIFGTNYAAQAAIE
AKVESFVLISTDKAVRPTNVMGTTKRVAELGLQALAQVENAKPNGTRFCM
VRFGNVLGSSGSVIPLFKKQIAQGGPITLTHKDITRYFMTIPEAAQLVIQ
AGAMGKGGDVFVLDMGESVKIADLARNLIHLSGLEVRSDENPDGDIEIRC
TGLRPGEKLYEELLIGDNVGKTAHERIMTANEEFLPLNEYNQLLDDLDTA
CHNFDHATIRQLLIDAPTGFAPVDGIGDLVWKAEQ
>VF2075 enolase
MSKIVKVLGREIIDSRGNPTVEAEVHLESGFVGMAAAPSGASTGSREALE
LRDGDKARFLGKGVLKAVAAVNGPIAEALVGKDAKNQAEIDQIMIDLDGT
DNKANFGANAILAVSLANAKAAAAAKSMPLYAHIAELNGTPGVFSMPLPM
MNIINGGEHADNNVDIQEFMIQPVGAKTLKEGLRIGAEVFHNLAKVLKSK
GYSTAVGDEGGFAPNLKSNAEALEVIAEAVAAAGYELGKDVTLAMDCAAS
EFFDKEAGIYNMKGEGKTFTSEEFNHYLAELANQFPIVSIEDGLDESDWT
GFKHQTELLGDKLQLVGDDLFVTNTKILAEGIEKGVANSILIKFNQIGSL
TETLAAIKMAKDAGYTAVISHRSGETEDATIADLAVGTAAGQIKTGSMSR
SDRVAKYNQLIRIEEALGEKAPFNGLKEVKGQ
>VF1115 PTS system, sucrose-specific IIBC component
MAKITTSMIQEILTAIGGKSNVIKCGNCMTRLRLTLHDDNLADRDTIKRI
AGVMGLVESDDQFQIVLGPGKAQTAAEMMNEMMEGEEDNSASTTAESRDL
KDVASEHKQKLKKKQTSAAQRFLSKFATIFTPLIPGFIAAGLLLGFATLL
DQIYIIGNESPNANLVDLILYMKVFSKGLFSFLSILIGYNAQQAFGGSGV
NGAILASLFVLGYNPDATSGIYSGMTDFFGHGIDPRGNIIGVLIAAIIGA
GVEKKVRQYMPDNLDMILTSVVTLLIMGAVTFVVIMPIGGVLFQGMSWLF
MNLNGNPIGSAILAGLFLISVMFGIHQGFVPVYFALMDAQGFNSLFPILA
MAGAGQVGAALALYAKANKDALLRTQVKGSIIPGFLGIGEPLIYGVTLPR
VKPFITACVGGAAGGFFIGLVSYMGLPVGLNTVFGPSGIVALPLMTSNAG
IFAGMLVFAAGLVISYVAGFLATWFFGTKNVDLS
>VF0806 N-acetylglucosamine repressor
MTGGQIGNVDLVKQLNSAAVYRLIDQKGPISRIQIADVSQLAPASVTKIT
RQLLERGLIKEVAQQASTGGRRAISLTTETSPFHSIAVRLGRDYIQLSLF
DLSTKELASEYQEFHYSNQEHLLDGLKLLLEGFISKNQDTIKQLIAIGIT
LPGLVNPETGVVEYMPNTDVNKLLLADFIKDNFNTECFVGNDVRGLALAE
HYFGASQDCYDSILVSVHRGTGAGIIVNGKVFLGHNRNVGEIGHIQIDPI
GDKCQCGNFGCLETVAADPAIIARVESLLKQGYPSSLSQLPKITMTDICH
AANHGDELATQTILRVGNQLGKAIAMTINLFNPQKIVIAGAITHADKILF
AAIRNCIKNQSLTTFHKDLPIVASELYDQPTIGAFSMVKRAMLNGVLLQK
LLDE
>VFA0470 6-phosphogluconate dehydrogenase
MKGDIGVIGLAVMGQNLILNMNDHGYKVVAHNRTAEKVDEFLQGPAKGTN
IVGAYSLQELVDKLESPRKIMLMVRAGDVVDSFIDKLVPLLDKGDIIIDG
GNTNFPDTNRRVAALKEKGIHFIGSGVSGGEEGARFGPSIMPGGSPEAWP
FVKPIFQAISAKTENNEPCCDWVGNDGAGHFVKMVHNGIEYGDMQLITEA
YQFMKDGLGMTHDEMQSVFIEWNKTELNSYLVEITSDILGYKDTDGEPLV
EKILDTAGQKGTGKWTGINALDMGIPLTLITESVFARCLSSLKDQRVEAE
ELFGKKESIVEGDKQVWIEALRQALLASKIISYAQGFMLMREASNENGWD
LNYGNVALMWRGGCIIRSAFLSNIRDAYDIDPELSFLGSDSYFKGILENS
MSAWRKVAAKSMEVGIPMPSMTSALTFLDGYTTARLPANLLQAQRDYFGA
HTYERVDKPKGEFFHTNWTGKGGDVSSTTYNS
>VFA0685 transaldolase
MTTKLEQLRKLTTVVADTGDIEAIAKYTPEDATTNPSLILKAAEITEYAP
LIDASIEYAKAQSNDKAQQVQDTCDMLAVNIGKEILKVVPGRISTEVDAR
LSYDTEGSVAKARQLIKMYNDAGITNDRILIKLASTWEGIRAAEILEKEG
INCNLTLLFSFAQARACAEAGVYLISPFVGRIMDWYKAKEGRDFEPSEDP
GVVSVTGIYNYYKEHGYNTVVMGASFRNIGEILELAGCDRLTISPNLLQE
LEEATGEVVEKLVDTNGNKARPAAMTHAEFLWDHNQDAMAVEKLAEGIRN
FAVDQGKLEAMIATKL